PIPERAZINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF

Abstract: The present invention relates to novel compound having strong antitumor activities of general formula (I), wherein R1 and R2 are independently hydrogen, substituted or unsubstituted C1-C8 alkyl, substituted or unsubstituted C3-C6 cycloalkyl, substituted or unsubstituted C2-C8 unsaturated alkyl, ketone, substituted or unsubstituted aryl, substituted or unsubstituted C1-C4 alkoxy, substituted or unsubstituted arylhydroxy, substituted or unsubstituted amino, C1-C4 lower ester, C1-C4 lower thioester, thiol, substituted or unsubstituted carboxyl, epoxy, substituted or unsubstituted C1-C4 lower thioalkoxy; or R1 and R2 are fused to form C3-C4 saturated or unsaturated chain; R3, R4, R5, R6 and R7 are independently hydrogen, halogen, hydroxy, nitro, C1-C4 lower ester, C1-C4 lower alkyl, C1-C4 lower thioalkyl, substituted or unsubstituted C3-C6 cycloalkyl, C1-C4 lower alkoxy, C1-C4 lower thioalkoxy, substituted or unsubstituted aryl, substituted or unsubstituted lower arylalkoxy, substituted or unsubstituted lower alkylamino, or lower alkyl substituted or unsubstituted carbamate; or among R3, R4, R5, R6 and R7, two adjacent groups are bonded with each other to form 1,2-phenylene or 2,3-naphthylene; X is oxygen, sulfur, or substituted or unsubstituted imino; Y is bonded at the 3-position or 4-position of the aromatic ring part wherein Y is oxygen or -NR8- (wherein, R8 is the same with the above-mentioned R3); Z is hydroxy, C1-C4 lower alkoxy, C1-C4 lower thioalkoxy, substituted or unsubstituted aryloxy, C1-C4 lower alkylamino, substituted or unsubstituted cycloamino containing 1-5 nitrogen atoms; A is nitrogen or -CH=; its pharmaceutically acceptable acid addition salts and process for the preparation thereof.

Description: Piperazine derivatives and process for the preparation thereof The present invention relates to new piperazine derivatives of the general formula (I) wherein and R2 are independently hydrogen, substituted or unsubstituted Ci-Cβ alkyl, substituted or unsubstituted Cs-Cc cycloalkyl, substituted or unsubstituted C2-C8 unsaturated alkyl, ketone, substituted or unsubstituted aryl, substituted or unsubstituted C1-C4 alkoxy, substituted or unsubstituted arylhydroxy, substituted or unsubstituted amino, C1-C4 lower ester, C1-C4 lower thioester, thiol, substituted or unsubstituted carboxyl, epoxy, substituted or unsubstituted C1-C4 lower thioalkoxy; or Ri and R2 are fused to form C3 _ C4 saturated or unsaturated chain; R3, R4, R5, Re and R7 are independently hydrogen, halogen, hydroxy, nitro, C1-C4 lower ester, C1-C4 lower alkyl, C1-C4 lower thioalkyl, substituted or unsubstituted C3-Q3 cycloalkyl, C 1 -C4 lower alkoxy, C1-C4 lower thioalkoxy, substituted or unsubstituted aryl, substituted or unsubstituted lower arylalkoxy, substituted or unsubstituted lower alkylamino, or lower alkyl substituted or unsubstituted carbamate; or among R3, R , R5, Re and Rv, two adjacent groups are bonded with each other to form 1,2-phenylene or 2,3-naphthylene; X is oxygen, sulfur, or substituted or unsubstituted imino; Y is bonded at the 3-position or 4-position of the aromatic ring part wherein Y is oxygen or -NRβ- (wherein, Re is the same with the above-mentioned R3.); Z is hydroxy, Ci-C4 lower alkoxy, C1-C4 lower thioalkoxy, substituted or unsubstituted aryloxy, C1-C4 lower alkylamino, substituted or unsubstituted cycloamino containing 1-5 nitrogen atoms; A is nitrogen or -CH=; its pharmaceutically acceptable acid addition salts and process for the preparation thereof. In the above definitions, Cj-Cβ alkyl means straight or branched alkyl group such as methyl, ethyl, propyl, isopropyl, n -butyl, isobutyl, tert-butyl, pentyl, iso-pentyl, hexyl, heptyl, octyl, 2-methylpentyl or the like. C1-C4 lower alkyl means methyl, ethyl, propyl, iso-propyl. n-butyl. iso-butyl or tert-butyl. Substituted or unsubstituted C3-C6 cycloalkyl means substituted or unsubstituted cycloalkyl such as cycloprop l, cyclobutyl, cyclopentyl, cyclohexyl, substituted cyclopropyl, substituted cyclopentyl. substituted cyclohexyl or the like. Cj-C 4 lower ester means a carboxyl group esterified by a lower alkyi group. C1-C4 lower alkoxy means methoxy, ethoxy, propoxy, isopropoxy, butyloxy, isobutyloxy, tert-butyloxy group or the like. Ci-Ci lower thioalkoxy means methylthio, ethylthio, propyl thio, isopropylthio, butylthio, isobutylthio, tert-butylthio group or the like. Ci-Cj lower alkylamino means methylamino, ethylaminυ. propylamino. butylaminυ group or the like. Arylυxy means phenoxy, substituted phenoxy, naphthyloxy or substituted naphthyloxy or the like. Cyclυamino group containing 1-5 nitrogen atoms means pyrrolidinyl. pyrrolinyl, imidazolyl, imidazolidinyl, pyrazolyl, pyrazolinyl, pyrazolidinyl, triazolyl, tetrazolyl, piperazinyl or the like. The present inventors had studied for a long time to find compounds having intensive antitumor activity. As the results, now we have finally found out the facts that the present compounds of the general formula (I) and acid addition salts thereof have not only prominent antitumor activities but very low toxicities. Accordingly, the one object of the present invention is to provide the novel compounds of the general formula(I) and acid addition salts thereof having not only prominent antitumor activities but very low toxicities. The other object of the present invention is to provide a process for the preparation of the compounds of general foιτnula(I ) and acid addition salts thereof. The compounds of the present invention can be mixed with pharmaceutically acceptable vehicles by a known method to give pharmaceutical compositions and the pharmaceutical compositions can be used to prevent or treat with various kinds of tumors of human beings or mammals. Therefore, another object of the present invention is to provide pharmaceutical compositions containing the compounds of the general formula(I) or acid addition salts thereof as active ingredients. Acids which can be reacted with the compounds of the general formula (I) to form acid addition salts are pharmaceutically acceptable inorganic or organic acids; for example, inorganic acids such as hydrochloric acid, bromic acid, sulfuric acid, phosphoric acid, nitric acid; organic acids such as formic acid, acetic acid, propionic acid, succinic acid, citric acid, maleic acid, malonic acid, glycolic acid, lactic acid; amino acids such as glycine, alanine, valine. leucine, isoleucine, serine, cysteine, cystine, asparaginic acid, glutamic acid, lysine, arginine, tyrosine, proline; sulfonic acids such as methane sulfonic acid, ethane sulfonic acid, benzene sulfonic acid, toluene sulfonic acid; or the like. Vehicles which can be used in the preparation of pharmaceutical compositions containing the compounds of the general formula(I) as active ingredients are sweetening agent, binding agent, dissolving agent, aids for dissolution, wetting agent, emulsifying agent, isotonic agent, adsorbent, degrading agent, antioxident, antiseptics, lubricating agent, filler, perfume or the like; such as lactose, dextrose, sucrose, mannitol, sorbitol, cellulose, glycine, silica, talc, stearic acid, stearin, magnesium stearate, calcium stearate, magnesium aluminum silicate, starch, gelatine, tragacanth gum, glycine, silica, alginic acid, sodium alginate, methyl cellulose, sodium carboxy methyl cellulose, agar, water, ethanol, polyethylenglycol, .polyvinyl pyrrolidone, sodium chloride, potassium chloride, orange essence, strawberry essence, vanila aroma or the like. Daily dosage of the compound of the general formula(I) may be varied depending on age, sex of patient and the degree of disease. Daily dosage is l.Omg to 5,000mg may be administered one to several times. The compounds of the general formula (I) according to the present invention may be prepared by the following scheme I. Scheme I (a) (b) (I) wherein Ri, R2, R3, R4, Rs, Re, R7, A, X, Y and Z are as defined above, and Lie is a leaving group such as halogen atom, sulfonyl or the like. The above process comprises reacting a compound of the general formula(a) with a -C(=X)- group-providing agent in organic solvent to obtain a compound of the general formula(b) and successively reacting the compound of the general formula(b) with a compound of the genera] formulate " ), to give the compound of the general formula(I). The used -C(=X) -group-providing agent preferably be selected from 1,1-carbonyldiimidazole, 1,1-carbonylthiodiimidazole, phosgene, thiophosgene, carbonyldiphenoxide, phenylchloroformate or the like. The reaction may be carried out in conventional organic solvent such as, for example, tetrahydrofuran, dichloromethane, chloroform, acetonitrile. And also the reaction is preferably carried out in the presence of coupling agent such as conventional inorganic or organic base. Such conventional inorganic or organic base used in the reaction means sodium hydride, potassium hydride, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, sodium bicarbonate, potassium bicarbonate, triethylamine, pyridine, DBU or the like, and 1-1.5 equivalent, preferably 1-1.1 equivalent thereof may be used. The reaction may be carried out between 3'C and boiling point of the solvent used, preferably at δO'C -lOO for 5 - 48 hours, preferably for 10 - 24 hours. -C(=X)-group-providing agent may be used in an amount of 1 - 1.5 equivalent, preferably 1-1.1 equivalent to the starting comjwund. A compound of the general formula(I) wherein Y is -NRs- may be prepared by the following scheme II Scheme II. (la) R β providing agent (lb) wherein, Ri, R2, R3, R4, R5, Re, R7, RR, A, X and Z are as defined above. A compound of the general formula(Ib) above may be prepared effectively by introducing Ra providing agent into a compound of the general formula(Ia). RP providing agent preferably used in the above reaction is Cj-Cs lower alkylhalogen, Ci-Cs lower alkyl sulfonate, substituted or unsubstituted C3-CS cycloalkylhalogen, arylhalogen, substituted or unsubstituted C CR cycloalkyl sulfonate, arylsulfonate, or the like. G -Cp lower alkylhalogen means methylchloride. methylbromide. methyliodide, ethylchloride, ethylbromide, ethyliodide, propylchloride, propylbromide, propyliodide, butylchloride, butylbromide, butyliodide, pentylchloride, pentylbromide, pentyliodide, ethylbromoacetate, or the like CI -CR lower alkyl sulfonate means methylsulfonate, ethylsulfonate, propylsulfonate, butylsulfυnate, pentylsulfonate, or the like. Substituted or unsubstituted C3-CR cycloalkylhalogen cyclopropylchloride, cyclopropylbromide, cyclopropyliodide, cyclobutylchloride, cyclobutylbromide, cyclobutyliodide, cyclopentylchloride, cyclopentylbromide, cyclopentyliodide, cyclohexylchloride, cyclohexylbromide, cyclohexyliodide, cyclopropyl methylchloride, cyclopropyl methylbromide, cyclopropyl methyliodide, cyclobutyl methylchloride, cyclobutyl methylbromide, cyclobutyl methyliodide, cyclopentyl methylchloride, cyclopentyl methylbromide, cycloijentyl methyliodide, cyclohexyl methylchloride, cyclohexyl methylbromide, cyclohexyl methyliodide, or the like. Arylhalogen means benzylchloride, benzylbromide, benzyliodide, benzoylchloride, benzoylbromide, benzoyliodide, toluylchloride, toluylbromide, toluyliodide, or the like. Substituted or unsubstituted C3-C8 cycloalkyl sulfonate means cyclopropyl sulfonate, cyclobutyl sulfonate, cyclopentyl sulfonate. cyclohexyl sulfonate, methylcyclopropyl sulfonate, methylcyclobutyl sulfonate, methylcyclopentyl sulfonate, methylcyclohexyl sulfonate. or the like. Arvlsulfonate means benzyl sulfonate, benzoyi sulfonate. toluvl sulfonate, or the like. More particularly, a compound of the general formula (la) may be reacted with an alkylating agent or arylating agent in a solvent at the temperature of 25-80 "C, for 30 minutes - 20 hours to give the object compound of the general formula(Ib). An alkylating agent or arylating agent may be used in amount of 1.0 - 1.5 equivalent. Conventional organic solvent such as for example tetrahydrofuran, dichloromethane, acetonitrile, dimethylforrnamide may be used in the above reaction. In the above reactions, if any acid material is formed, any basic material may be preferably added as scavenger in order to eliminate the acid material from the reaction phase. Such basic material may be alkali metal hydroxide, alkali earth metal hydroxide, alkali metal oxide, alkali earth metal oxide, alkali metal carbonate, alkali earth metal carbonate, alkali metal hydrogen carbonate, alkali earth metal hydrogen carbonate such as sodium hydroxide, potassium hydroxide, calcium hydroxide, magnesium hydroxide, magnesium oxide, calcium oxide, potassium carbonate, sodium carbonate, calcium carbonate, magnesium carbonate, magnesium bicarbonate, sodium bicarbonate, calcium bicarbonate or the like, or organic amines. The compound of the general formula(a) is described in prior art ( J. Med. Chem., 1992,- 35, 3784, 3792 ) or may be prepared in a similar method to the art. Hereinafter the present invention will be described in more details with reference to following examples but it is not intended to limit the scope of the invention thereinto. Compounds of the general formula(I) and formula(Ib ) are prepared in following examples according to the above-mentioned process. ( I ) (lb) wherein Rj, R2, R3, 4, R5, Re, RT, A, X, Y, Z are the same above. 11 - 0 [5 0 25 30 35 Example 1 l-[(5,6-Dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4-(2-methylthio phenyDpiperazine-" a) Phenyl N-(5,6-dimethyl-2-methoxypyridin-3-yl)carbamate- 3-Amino-5,6-dimethyl-2-methoxypyridine(1.52g, O.Ol o and phenylchloroforrnate(1.56g, O.OlmoI) were dissolved in dichloromethane and was stirred at room temperature for 2 hours. The mixture was concentrated under the reduced pressure to remove the solvent. The concentrate was purified by column chromatography(ethylacetate : hexane = 1.'6) to obtain the titled compound, yield: 92 % 1H-NMR(CDCl3) S : 2.18(3H,s), 2.36(3H,s), 4.00(3H,s), 7.31 (5H.m). 8.07(lH,s) b) l-[(5,6-Dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4-(2-methyl thiophenyDpiperazine: Phenyl N-(5,6-ctimethyl-2-methoxypyridin-3-yl)carbamate(136mg, O.δmmol) and l-(2-methylthiophenyl)piperazine(104mg, O.δmmol) were dissolved in anhydrous tetrahydrofuran and DBU(76mg, O.δmmol) was added. The mixture was stirred at room temperature for 2 hours and concentrated under the reduced pressure to remove tetrahydrofuran. The concentrate was purified by column chromatography(ethylacetate : hexane = 1 : 2) to obtain the titled compound. yield : 59% m.p. : 167-169 C 1H NMR(CDCl3) 5 : 2.21 (3H,s), 2.43(6H,s), 3.06(4H,t), 3.68(4H,t), 4.09(3H,s), 6.89(lH,s), 7.06(lH,m), 7.14(3H,s), 8.26(lH,s) Example 2 l-[(5,6-Dimethylϊ-2-methoxypyridin-3-yl)aminocarbonyl]-4-(2-isopropeny lphenyDpiperazine : Phenyl N-(5,6-dimethyl-2-methoxypyridin-3-yI)carbamate and l-(2-isopropenylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 62 % m.p. : 139-140 C 1H NMR(CDCl3) δ : 2.20(3H,s), 2.21(6H,s), 3.10(4H,t), 3.64(4H,t), 3.84(3H,s), 5.07(lH,s), 5.13(lH,s), 6.64(lH,s), 6.98(lH,s), 7.04(3H,dd), 7.18QH,d), 7.91(lH,s) Example 3 l-[(5,6-Dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4-(2,3,5,6- tetramethylphenyDpiperazine: Phenyl N-(5,6-dimethyl-2-methoxypyridin-3-yl)carbamate and l-(2,3,5,6-tetramethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 71% m.p. : 190-192'C 1H NMR(CDCb) δ : 2.21(15H,s), 2.42(3H,s), 3.17(4H,t), 3.61 (4H,t), 4.08(3H,s), 6.84(lH,s), 6.89(lH,s), 8.26(lH,s) Example 4 l-[(5-Ethyl-6-methyl-2-methoxypyridin-3-yl)aminocarbonyl]-4-(2-meth ylthiophenyDpiperazine: Phenyl N-(5-ethyl-6-methyl-2-methoxypyridin-3-yl)carbamate and l-(2-methylthiophenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound, yield : 56% m.p. : 160-161'C 1H NMR(CDCl3) δ : 1.19(3H,t), 2.43(3H,s), 2.50(3H,s), 2.58(2H,q), 3.07(4H,t), 3.69(4H,t), 4.15(3H,s), 6.93(lH,s), 7.06(lH,m), 7.14(3H,m), 8.35(lH,s) Mass(EI) m/z : Calcd for C21H28N4O2 400.1932, found 400.1925 Example 5 1 -[ (5-Ethy l-6-m ' ethyl-2-methoxypyridin-3-y 1) aminocarbonyl] -4- (2-isopropenylphenyl)piperazine: Phenyl N-(5-ethyl-6-methyl-2-methoxypyridin-3-yl)carbamate and l-(2-isopropenylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 51% .p. : 185-1871C 1H NMR(CDCl3) 5 : 1.18(3H,t), 2.21 (3H,s), 2.42(3H,s), 2.56(2H,q), 3.08(4H,t), 3.62(4H,t), 4.03(3H,s), 5.08(lH,s), 5.13(lH,s), 6.90(lH,s), 7.02(3H,m), 7.18(lH,d), 8.25(lH,s) Example 6 l-[(5-Ethyl-2-methoxy-6-methylρyridin-3-yl)aminocarbonyl]-4-(2,3,5,6-t etra ethylphenyDpiperazine: Phenyl N-(5-ethyl-2-methoxy-6-methylpyridin-3-yl)carbamate and l-(2,3,5,6-tetramethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 69% m.p. : 176-1771C 1H NMR(CDCl3) <y : 1.19(3H,t), 2.21(12H,s), 2.44(3H,s), 2.57(2H,q), 3.17(4H,t), 3.62(4H,t), 4.06(3H,s), 6.84(lH,s), 6.92(lH,s), 8.30(lH,s) Example 7 l-[(5-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4- (3 - thiophenyDpiperazine: Phenyl N-(5-ethyl-2-methoxy-6-methylpyridin-3-yl)carbamate and l-(3-thiophenyI)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 63% m.p. : 108-110"C H NMR(CDCl3) : 1.17(3H,t), 2.37(3H,s), 2.49(2H,q), 3.28(4H,t), 3.60(4H,t), 3.98(3H,s), 6.87(4H,m), 6.98(lH,s), 8.18QH,s) Example 8 l-[(2-Methoxy-6-methyl-5-propylpyridin-3-yl)aminocarbonyl]-4-(3,5- dimethoxyphenyDpiperazine: Phenyl N-(2-metfooxy-6-methyl-5-propylpyridin-3-yl)carbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 67% m.p. : 82-84 TC 1H NMR(CDCl3) : 0.94(3H,t), 1.58(2H,m), 2.37(3H.s), 2.49(2H,q), 3.25(4H,t), 3.66(4H,t), 3.78(6H,s), 3.99(3H,s), 6.07(3H,m), 6.88(lH,s), 8.16(lH,s) Mass(EI) m/z : Calcd for CasH^O* 428.2423, found 428.2447 Example 9 1 -[ (2-Methoxy -6-methyl-5-propylpyridin -3 -y aminocarbony 1] -4- (3,5- dimethylphenyDpiperazine Phenyl N-(2-methoxy-6-methyl-5-propylpyridin-3-yl)carbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 64% m.p. : 145-146X 1H NMRtCDCla) S : 0.95(3H,t), 1.59(2H,m), 2.29(6H,s), 2.41(3H,s), 2.49(2H,q), 3.24(4H,t), 3.67(4H,t), 3.98(3H,s), 6.59(3H,m), 6.89(lH,s), 8.17(lH,s) Mass(EI) m z : Calcd for C23H 32 N 4 θ4 428.2423, found 428.2385 Example 10 l-[(2-Methoxy-6-methyl-5-propylpyridin-3-yl)aminocarbonyl]-4-(3,5- difluorophenyDpiperazine: Phenyl N-(2-methoxy-6-methyI-5-propylpyridin-3 ~ yl)carbamate and l-(3,5-difluorophenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound, yield : 57% m.p. : 121-123'C 1H NMR(CDCl3) : 0.95(3H,t), 1.59(2H,m), 2.38(3H,s), 2.50(2H,q), 3.29(3H,t), 3.66(3H,t), 4.00(3H,s), 6.28(lH,m), 6.36(2H,d), 6.87(lH,s), 8.17(lH,s) Example 11 l-[(2-Methoxy-6-methyl-5-propylpyridin-3-yl)aminocarbonyl]-4-(2- methoxypheny piperazine: Phenyl N-(2-methoxy-6-methyl-5-propylpyridin-3-yI)carbamate and l-(2-methoxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 71% m.p. : 109-llOt: 1H NMR(CDCl3) : 0.95(3H,t), l.δ9(2H,m), 2.37(3H,s), 2.49(2H,q), 3.12(4H,t), 3.70(4H,t), 3.89(3H,s), 3.97(3H,s), 6.91(4H,m), 6.95(lH,s), 5 8.19(lH,s) Example 12 l-[(6-Ethyl-2-methoxy-5-methylpyridin-3-yl)aminocarbonyl]-4-(3,5- dimethoxyphenyDpiperazine-' 10 Phenyl N-(6-ethyI-2-methoxy-5-methylpyridin-3-yl)carbamate and l-(3,5-dirnethoxyphenyI)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 65% m.p. : 115-1161C lδ 1H NMR(CDC1 3 ) δ : 1.21 (3H,t), 2.21 (3H,s), 2.65(2H,q), 3.27(4H,t), 3.64(4H,t), 3.79(6H,s), 3.98(3H,s), 6.09(3H,m), 6.86(lH,s), 8.12(lH,s) Mass(EI) m z : Calcd for C22H30N4O4 414.2267, found 414.2240 Example 13 20 l-[(6-Ethyl-2-methoxy-5-methylpyridin-3-yI)aminocarbonyl]-4-(3,5-dim ethylphenyDpiperazine: Phenyl N-(6-ethyl-2-methoxy-5-methylpyridin-3-yl)carbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. 25 yield : 61% m.p. : 135-1361C 1H NMR(CDCl3) δ : 1.22(3H,t), 2.21(3H,s), 2.29(6H,s), 2.65(2H,q), 3.24(4H,t), 3.66(4H,t), 3.98(3H,s), 6.59(3H,m), 6.87(lH,s), 8.12(lH,s) Mass(EI) m/z : Calcd for C22H30N4O2 382.2368, found 382.2376 30 Example 14 l-[(6-Ethyl-2-methoxy-5-methylpyridin-3-yl ) aminocarbonyl]-4-(3-hydro xy phenyl )piperazine: Phenyl N-(6-ethyl-2-methoxy-5-methylpyridin-3-yl)carbamate and 35 l-(3-hydroxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 56% m.p. : 168-17CC 1H NMRtCDCls) 0 s : 1.21 (3H,t), 2.20(2H,s), 2.63(2H,t), 3.28(4H,t), 3.68(4H,t), 3.98(3H,s), 6.41(lH,d), 6.55(lH,d), 6.84(lH,m), 6.87(lH,s), 7.13QH,t), 8.10(lH,s) Mass(EI) m/z : Calcd for C20H26N4O3 370.2004, found 370.1992 Example 15 l-[(2-Methoxy-5-methyl-6-propylpyridin-3-yl)aminocarbonyl]-4-(3,5- dimethoxyphenyDpiperazine: Phenyl N-(2-methoxy-5-methyl-6-propylpyridin-3-yl)carbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound, yield : 57% m.p : 121-122°C 1H NMR(CDCl3) δ : 0.96(3H,t), 1.67(2H,m), 2.21 (3H,s), 2.58(2H,t), 3.26(4H,t), 3.68(4H,t), 3.79(6H,s), 3.97(3H,s), 6.14(3H,m), 6.89(lH,s), 8.11(lH,s) Mass(EI) m/z : Calcd for C23H32N4O4 428.2423, found 428.2423 Example 16 l-[(2-Methoxy-5-methyl-6-propylpyridin-3-yl)aminocarbonyl]-4-(3,5-di methy lpheny 1 )piperazine: Phenyl N-(2-methoxy-5-methyl~6-propylpyridin-3-yl)carbamate and l-(3,5-d nethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 54% m.p. : 138-139t 1H NMR(CDCl3) <S : -0.96(3H,t), 1.72(2H,m), 2.21 (6H,s), 2.30(3H,s), 2.59(2H,t), 3.28(4H,t), 3.76(4H,t), 3.97(3H,s), 6.70(3H,m), 6.87(lH,s), 8.11 (lH,s) Mass (ED m/z : Calcd for C23H32N4O2 396.2525, found 396.2432 Example 17 l-[(2-Methoxy-5-methyI-6-propylpyridin-3-yl)aminocarbonyl]-4-(3- hydroxyphenyDpiperazine: Phenyl N-(2-methoxy-5-methyl-6-propylρyridin-3-yl)carbamate and l-(3-hydroxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound, yield : 52% m.p. : 153-155'C l H NMR(CDCl3) δ : 0.95(3H,t), 1.69(2H,m), 2.19(3H,s), 2.59(2H,t), 3.22(4H,t), 3.68(4H,t), 3.97(3H,s), 6.42(lH,d), 6.52(lH,d), 6.87(lH,s), 7.12(lH,t), 8.09(lH,s) Mass(EI) m/z : Calcd for C21H28N4O3 384.2161, found 384.2153 Example 18 1 -[N- ( 2-Methoxy -6,7-dihy dro~5H-cy clopenta[b]py ridin -3 -y 1 ) aminocarbonyl]-4-(3,5-dimethoxyphenyl)piperazine: Phenyl N-(2-methoxy-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl) carbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 59% m.p. : 143- 14 TC 1H NMR(CDC1 ) δ : 2.10(2H,m), 2.87(4H,m), 3.12(4H,t), 3.70(4H,t), 3.78(6H,s), 4.00(3H,s), 6.08(3H,m), 6.90(lH,s), 8.24(lH,s) Example 19 l-[N-(2-Methoxy-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl) aminocarbonyl] -A- (3,5-dimethylphenyl)piperazine: Phenyl N-(2-methoxy-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl) carbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 55% m.p. : 183-185TC *H NMR(CDCl3) δ : 2.08(2H,m), 2.28(6H,s), 2.87(4H,m), 3.22(4H,t), 3.67(4H,t), 4.00(3H,s), 6.57(3H,m), 6.89(lH,s), 8.24(lH,s) Example 20 l-[(2-Methoxy-5,6,7,8-tetrahydroquinolin-3-yl ) aminocarbonyl]-4-(3,5- dimethoxyphenyDpiperazine: Phenyl N-(2-methoxy-5,6,7,8-tetrahydroquinoline-3-yI ) carbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound, yield : 54% m.p. : 161-163'C Η NMR(CDCl3) <5 : 1.75(2H,m), 1.84(2H,m), 2.67(2H,t), 2.73(2H,t), 3.27(4H,t), 3.71(4H,t), 3.79(6H,s), 3.97(3H,s), 6.10(3H,m), 6.90(lH,s), 8.07(lH,s) Example 21 l-[(2-Methoxy-5,6,7,8-tetrahydroquinolin-3-yl)aminocarbonyl]-4-(3,5- dimethyphenyl )piperazine: Phenyl N-(2-methoxy-5,6,7,8-tetrahydroquinolin-3-yl)carbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 51% m.p. : 143-144TC 1H NMR(CDCl3) 5 : 1.75(2H,m), 84(2H,m), 2.30(6H,s), 2.68(2H,t), 2.72(2H,t), 3.26(4H,t), 3.67(4H,t), 3.97(3H,s), 6.61(3H,m), 6.91(lH,s), 8.07(lH,s) Example 22 l-[(5,6-Dimethyl-2-methoxypyridin-3-yI)aminothiocarbonyl]-4-(3,5- dimethylphenyDpiperazine: Phenyl N-(5,6-dimethyl-2-methoxypyridin-3-yl)thiocarbamate(200mg, 0.7mmol) and l-(3,5-dimethylphenyl)piperazine(154mg, 0.7mmol) were dissolved in anhydrous tetrahydrofuran and DBU(106mg) was added thereto. The mixture was stirred at room temperature for 2 hours and concentrated under the reduced pressure to remove the solvent. The concentrate was purified by column chromatography( ethylacetate •' hexane = 1 •" 2 ) to obtain the titled compound. yield : 50% m.p. : 192-193 TC 1H NMR(CDCl3) δ : 2.21 (3H,s), 2.29(6H,s), 2.36(3H,s), 3.33(4H,t), 3.96(3H,s), 4.09(4H,t), 6.57(3H,m), 7.33(lH,s), 8.11(lH,s) Mass(EI) m/z : Calcd for C21H28N4O1S1 384.1983, found 384.1992 Example 23 l-[(5,6-DimetiιyI-2-methoxypyricin-3-yl ) aminothiocarbonyl]-4-(3,5- difluorophenyDpiperazine-' Phenyl N-(5,6-dimethyl-2-methoxypyridin-3-yl)thiocarbamate and l-(3,5-difluorophenyl)piperazine were reacted by the same way with the example 22 to obtain the titled compound. yield : 47% m.p. : 60-62 TC 1H NMR(CDCl3) δ : 2.21 (3H,s), 2.36(3H,s), 3.39(4H,t), 3.96(3H,s), 4.10(3H,t), 6.29(3H,m), 7.33(lH,s), 8.14(lH,s) Example 24 l-[(5,6-Dimethyl-2-methoxypyridin-3-yl)aminothiocarbonyl]-4-(3- hydroxyphenyDpiperazine: Phenyl N-(5,6-dimethyl-2-methoxypyridin-3-yl)thiocarbamate and l-(3-hydroxyphenyl)piperazine were reacted by the same way with the example 22 to obtain the titled compound. yield : 43% m.p. : 185-186 * C X H NMR(CDCk) δ : 2.14(3H,s), 2.36(3H,s), 3.25(4H,t), 3.89(3H,s), 4.09(4H,t), 6.30(lH,d), 6.36(2H,m), 7.03(lH,t), 7.48(lH,s), 8.56(lH,s) Example 25 l-[(2-Metiιoxy-6-metnyl-5-propylpyridin-3-yl)aminothiocarbonyI]-4-(3,5 -dimethoxyphenyDpiperazine: Phenyl N-(2-methoxy-6-methyl-5-propylpyridin-3-yl)thiocarbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 22 to obtain the titled compound, yield : 55% .p. : 143-144 t 1H NMR(CDCb) ^^ 0.93(3H,t), 1.66(2H,m), 2.17(3H,s), 2.65(2H,t), 3.38(4H,t), 3.79(6H,s), 3.98(3H,s), 4.15(4H,t), 6.11 (3H,m), 7.43(lH,s), 8.25(lH,s) Example 26 l-[(2-Methoxy-5-methyl-6-propylpyridin-3-yl ) aminothiocarbonyl]-4-(3,5 -dimethoxyphenyDpiperazine: Phenyl N-(2-methoxy-5-methyI-6-propylpyridin-3-yl)thiocarbamate and l-(3,5-dimethoxyphenyl)ρiperazine were reacted by the same way with the example 22 to obtain the titled compound. yield : 52% m.p. : 183-184 r 1H NMR(CDCl3) δ : 0.98(3H f t), 1.72(2H,m), 2.17(3H,s), 2.62(2H,t), 3.39(4H,t), 3.79(6H,s), 3.96(3H,s), 4.19(4H,t), 6.15(3H,m), 7.42(lH,s), 8.08(lH,s) Mass(EI) m/z : Calcd for C23H32N θ 3 Si 444.2195, found 444.2171 Example 27 l-[(2-Methoxy-5-methyl-6-propylpyridin-3-yl)aminothiocarbonyI]-4-(3,δ -dimethylphenyDpiperazine: Phenyl N-(2-methoxy-5-methyl-6-propylpyridin-3-yl)thiocarbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 22 to obtain the titled compound, yield : 49% m.p. : 195-197 * C *H NMR(CDCl3) : 0.98(3H,t), 1.73(2H,m), 2.18(6H,s), 2.34(3H,s). 2.62(2H,t), 3.47(4H,t), 3.96(3H,s), 4.01(4H,t), 6.59(3H,m), 7.02(lH,s), 7.99(lH,s) Mass(EI) m/z : Calcd for C23H 3 2N θ 1 S ) 412.2296, found 412.2266 Example 28 l-[(2-Methoxy-5-methyl-6-propylpyridin-3-yl)aminothiocarbonyl]-4-(3- hydroxyphenyDpiperazine: Phenyl N-(2-methoxy-5-methyl-6-propylpyridin-3-yl)thiocarbamate and l-(3-hydroxyphenyl)piperazine were reacted by the same way with the example 22 to obtain the titled compound. yield : 48% m.p. : 160-162t 1H NMRCCDCb) tf : 0.98(3H,t), 1.72(2H,m), 2.22(3H,s), 2.61 (3H,t), 3.31 (4H,t), 3.95(3H,s), 4.10(4H,t), 6.45(3H,m), 7.12(lH,t), 7.41(lH,s), 8.08(lH,s) Mass (ED m/z : Calcd for C2iH 28 N θ 2 S 1 400.1932, found 400.1969 Example 29 l-[N-(2-Methoxy-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)aminothiocar bonyl]-4-(3,5-dimethoxyphenyl)piperazine: Phenyl N-(2-methoxy-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl) thiocarbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 22 to obtain the titled compound. yield : 55% m.p. : 169-170 "C 1H NMR(CDCb) : 2.10(2H,m), 2.89(4H,m), 3.30(4H,t), 3.77(6H,s), 3.98(3H,s), 4.20(4H,t), 6.05(3H,m), 7.37(lH,s), 8.25(lH,s) Example 30 l-[N-(2-Methoxy-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)aminothiocar bonyl]-4- (3,5-dimethylphenyl)piperazine: Phenyl N-(2-methoxy-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yI) thiocarbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 22 to obtain the titled compound. yield : 53% m.p. : 159-1611 1H NMR(CDCl3) δ : 2.09(2H,m), 2.28(6H,s), 2.87(4H,m), 3.67(4H,t), 4.00(3H,s), 4.21(4H,t), 6.57(3H,m), 6.93(lH,s), 8.24(lH,s) Example 31 l-[(2-Methoxy-5,6,7,8" etrahydroquinobn-3-yl)aminothiocarbonyl]-4-(3,5- dimethoxyphenyDpiperazine: Phenyl N-[(2-metihoxy-5,6,7,8-tetrahydroquinolin-3-yl)thiocarbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 22 to obtain the titled compound. yield : 56% m.p. : 160-161 t 1H NMR(CDCb) δ : 1.77(2H,m), 1.83(2H,m), 2.70(2H,t), 2.76(2H,t), 3.38(4H,t), 3.79(6H,s), 3.96(3H,s), 4.16(4H,t), 6.12(3H,m), 7.45(lH,s), 8.03(lH,s) Example 32 l-[(2-Methoxy-5,6,7,8-tetrahydroquinolin-3-yl)aminothiocarbonyl]-4-(3,5- dimethylphenyDpiperazine: Phenyl N-(2-methoxy-5,6,7,8-tetrahydroquinohn-3-yl)thiocarbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 22 to obtain the titled compound. yield : 54% m.p. : 200-2011 1H NMR(CDCb : 1.77(2H,m), 1.84(2H,m), 2.34(6H,s), 2.71 (3H,t), 2.75(3H,t), 3.47(4H,t), 3.97(3H,s), 4.42(4H,t), 6.35(3H,m), 6.91(lH,s), 7.91 (lH,s) Example 33 1 -[(5,6-Dimethyl-2-methylaminopyridin-3-yl)aminocarbonyl] -4- (3,5- dimethoxyphenyDpiperazine: Phenyl N-(5,6-dimethyl-2-methylaminopyridin-3-yI)carbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound, yield : 53% m.p. : 150-151 TC *H NMR(CDC ) : 2.29(3H,s), 2.48(3H,s), 3.29(4H,t), 3.45(3H,s), 3.77(6H,s), 3.79(4H,t), 6.10(3H,m), 7.40(lH,s) Example 34 l-[(5,6-Dime yl-2-me ylaminopyridin-3-yl)aminocarbonyl]-4-(3,5- dimethylphenyDpiperazine: Phenyl N-(5,6-dimemyl-2-methylaminopyridin-3-yI)carbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 52% m.p. : 160-1621C 1H NMR(CDCb) ό\' 2.30(9H,s), 2.48(3H,s), 3.31 (4H,t), 3.46(3H,s), 3.78(4H,t), 6.60(3H,m), 7.41 (lH,s) Example 35 l-[(5-Ethyl-6-memyl-2-methylaminopyridin-3-yl)aminocarbonyl]-4-(3,5- di ethylphenyDpiperazine: Phenyl N-(5-ethyl-6-methyl-2-methylaminopyridin-3-yl)carbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound, yield : 56% m.p. : 143-145X l H NMR(CDCb) δ : 1.22(3H,t), 2.28(6H,s), 2.52(3H,s), 2.72(2H,q), 3.29(4H.t), 3.45(3H,s), 3.78(4H,t), 6.59(3H,m), 7.41 (lH.s) Example 36 l-[(2-Methylamino-6 f 7-dihydro-5H-cyclopenta[b]pyridin-3-yl) aminocarbonyl]-4-(3,5-dimethoxyphenyl)piperazine: Phenyl N-(2-methylamino-6,7-ώhydro-5H-cy openta[b]pyridin-3-yl) carbamate and l-(3,5-climethoxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 49% Η NMR(CDCb) δ : 2.09(2H,m). 2.95(4H,m ) , 3.30(4H.t ) . 3.47(3H.s). 3.77(4H,t), 3.80(6H,s), 6.10(3H,m), 7.49(lH,s) Example 37 l-[(2-Methylamino-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl) aminocarbonyl]-4-(3,5-dimethylphenyl)piperazine: Phenyl N-(2-methylamino-6,7-dihydro-5H-cyclυpenta[b3pyridin-3-yl) carbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 48% m.p. : 185-187'C Η NMR(CDCb) 5 : 2.14(2H,m), 2.29(6H,s), 2.95(4H,m) t 3.32(4H,t). 3.47(3H,s), 3.79(4H,t), 6.59(3H,m), 7.48(lH,s) Example 38 l-{[5,6-Dimethyl-2-(4'-t-butoxycarbonylpii3erazinyl)pyridin-3-yl] aminocarbonyl}-4-(3,5-dimethoxyphenyl)piperazine: Phenyl N-[5,6-dimethyl-2-(4'-t-butoxycaι-bonylpiperazinyl)pyridin-3-yl] carbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 58% m.p. : 74-75'C 1H NMR(CDCb) : 1.46(9H,s), 2.20(3H,s), 2.21 (3H,s), 2.90(4H,t), 3.20(4H,t), 3.55(4H,t), 3.65(4H,t), 3.98(3H,s), 6.02(3H,m), 8.20(lH,s) Example 39 l-{[5,6-Dimethyl-2-(4'-t-butoxycarbonylpiperazinyl)pyridin-3-yI] aminocarbonyl}-4-(3,5-dimethylphenyl)piperazine: Phenyl N-[5,6-dimethyl-2-(4'-butoxycarbonylpiperazinyl)pyridin-3-yl] carbamate and l-(3,5-dimethylphenyI)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 56% m.p. : 155-156 * C Η NMR(CDCb) δ : 1.48(9H,s), 2.22(3H,s ) , 2.29(6H.s), 2.35(3H,s), 2.95(4H,t), 3.25(4H,t). 3.57(4H,t), 3.67(4H,t), 6.59(3H,m), 8.21 (lH,s ) Example 40 1 -{[δ-Ethy l-6-methyl~2- (4 ' -t-butoxycarbonylpiperazinyl )pyridin-3-y 1] aminocarbonyl}-4-(3,δ-dimethoxyphenyl)piperazine: Phenyl N-[5-ethyl-6-methyl-2- (4' -t-butoxycarbonylpiperazinyl) pyridin-3-yl]carbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield : 52% m.p. : 119-120'C 1H NMR(CDCb) 5 : 1.25<3H,t), 1.48(9H,s), 2.38(3H,s), 2.51 (2H,q), 2.96(4H,t), 3.27(4H,t), 3.58(8H,m), 3.78(6H,s), 6.08(3H,m), 8.24(lH,s) Example 41 l-{[5-Ethyl-6-methyl-2-(4'-t-butoxycarbonylpiperazinyl ) pyridin-3-yl] aminocarbonyl}-4-(3,5-dimethylphenyl)piperazine: Phenyl N-[5-ethyl-6-methyl-2-(4' -t-butoxycarbonylpiperazinyl) pyridin-3-yl]carbamate and l-(3,5-dimethyIphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound, yield : 50% m.p. : 126-128'C Η NMR(CDCb) 5 : 1.20(3H,t), 1.49(9H,s), 2.29(6H,s), 2.39(3H,s), 2.52(2H,q), 2.98(4H,t), 3.23(4H,t), 3.59(8H,m), 6.59(3H,m), 7.58(lH,s), 8.26(lH,s) Example 42 l-[(5,6-Dimethyl-2-piperazinylpyridin-3-yl)aminocarbonyl]-4- (3,δ-dimethoxyphenyl)piperazine: l-{[5,6-Dimethyl-2-(4'-t-butoxycarbonylpiperazinyl)pyridin-3-yl] aminocarbonyl}-4-(3,5-ciimethoxyphenyl)piperazine(0.218g, 0.4mmol) was dissolved in dichloromethane •' nitromethane = 2 •' KlOml) and anisole(0.26g, 2.4mmol) and aluminum chloride (0.3g, 2,4mmol) were added slowly thereto. The mixture was stirred at room temperature for 20min. Distilled water (50ml) was added into the mixture and the mixture was made basic with saturated NaHCθ3 and extracted with dichloromethane and then concentrated under the reduced pressure to remove the solvent. The concentrate was purified by column chromatography (methanol : dichloromethane = 8:1) to obtain the titled compound. yield : 89% m.p. : oil phase 1H NMR(CDCb) δ : 2.21(3H,s), 2.35(3H,s), 3.02(4H,t), 3.34(4H,t), 3.59(4H,t), 3.62(4H,t), 3.78(6H,s), 6.08(3H,m), 8.18(lH,s) Example 43 l-[(5,6-Dimethyl-2-piperazinylpyridin-3-yl)aminocarbonyl]-4-(3,5- dimethylphenyDpiperazine: l-{[5,6-Dimethyl-2-(4'-t-butoxycarbonylpii3erazinyl)pyridin-3-yl] aminocarbonyl}-4-(3,5-dimethylphenyl)piperazine was reacted by the same way with the example 42 to obtain the titled compound. yield : 85% m.p. : 103-105°C 1H NMR(CDCb) δ : 2.16(3H,s), 2.24(6H,s), 2.40(3H,s), 3.30(4H,t), 3.44(4H,t), 3.50(4H,t), 3.81(4H,t), 6.95(3H,rn), 7.72(lH,s) Example 44 l-[(5-Ethyl-6-methyl-2-piperazinylpyridin-3-yl)aminocarbonyl]-4-(3,5- dimethoxyphenyDpiperazine- * l-{[5-Ethyl-6~methyl-2-(4'-t-butoxycarbonylpiperazinyI)pyridin-3-yl] aminocarbonyl}-4-(3,5-dimethoxyphenyl)piperazine was reacted by the same way with the example 42 to obtain the titled compound, yield : 88% m.p. : 68-70'C J H NMR(CDCb) δ : 1.20(3H,t), 2.40(3H,s), 2.52(2H,q), 2.75(4H,t), 3.32(4H,t), 3.70(8H,m), 3.78(6H,s), 6.09(3H,m), 7.68(lH,s), 8.23(lH,s) Example 45 l-[(5-Ethyl-6-methyl-2-piperazinylpyridin-3-yl)aminocarbonyl]-4-(3,5- dimethylphenyDpiperazine: l-([5-Ethyl-6-methyl-2-(4'-t-butoxycarbonylpiperazinyl)pyridin-3-yl] aminocarbonyI)-4-(3,5-dimethylphenyl)piperazine was reacted by the same way with the example 42 to obtain the titled compound. yield : 85% m.p. : 100-102'C 1H NMR(CDCb) ^ : 1.20(3H,t), 2.28(6H,s), 2.39(3H,s), 2.65(2H,q), 2.76(4H,t), 3.00(4H,t), 3.23(4H,t), 3.70(4H,t), 6.58(3H,m), 7.66(lH,s), 8.24(lH,s) Example 46 l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(3,5- dimethoxyphenyDpiperazine: Phenyl N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)carbamate(200mg, 0.67mmol) and l-(3,5-dimethoxyphenyl)piperazine(150mg, 0.67mmol) were dissolved in anhydrous tetrahydrofuran (15ml) and DBlXlOOmg, 0.67mmol) was added. The mixture was stirred at room temperature for 2 hrs and concentrated under the reduced pressure to remove tetrahydrofuran. The concentrate was purified by column chromatography (ethylacetate : hexane = l-'2) to obtain the titled compound, yield : 83% m.p. : 149-151°C 1H NMR(CDCb) δ : 2.57(3H,s), 2.65(3H,s), 3.28(4H,t,J=4.65Hz), 3.70(4H,t. J=4.65Hz), 3.79(6H,s), 4.06(3H,s), 6.09(lH,s), 6.14(2H,d),6.94(lH,s), 8.87(lH,s) Example 47 l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(3,5- dimethy lpheny 1 )piperazine: Phenyl N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)carbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 46 to obtain the titled compound. yield : 82% m.p. : 66-69°C 1H NMR(CDCb) r5 : 2.31 (6H,s), 2.57(3H,s), 2.65(3H,s), 3.08(4H,t), 3.30(4H,t), 4.10(3H,s), 6.71(2H,d), 6.94(lH,s), 8.89(lH,s) Example 48 l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(3,5- difluorophenyDpiperazine: Phenyl N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)carbamate and l-(3,5-difluorophenyl)piperazine were reacted by the same way with the example 46 to obtain the titled compound. yield : 77% m.p. : 180-181°C 1H NMR(CDCb) δ : 2.57(3H,s), 2.65(3H,s), 3.33(4H,t,J=5.0Hz), 3.74(4H,t, J=5.0Hz), 4.07(3H,s), 6.37(lH,s), 6.46(2H,d), 6.93(lH,s), 8.85(lH.s) Example 49 l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(3,5- dichlorophenyDpiperazine: Phenyl N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)carbamate and l-(3,5-dichlorophenyl)piperazine were reacted by the same way with the example 46 to obtain the titled compound. yield : 81% m.p. : oil phase 1H NMR(CDCb) : 2.57(3H,s), 2.65(3H,s ) , 3.34(4H,t), 3.78(4H,t), 4.04(3H,s), 6.93(3H,m), 8.80(lH,s) Example 50 l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(2,3- dimethylphenyDpiperazine: Pheny N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)carbamate and l-(2,3-dimethylphenyl)piperazine were reacted by the same way with the example 46 to obtain the titled compound. yield : 81% m.p. : 173-1741C Η NMR(CDCb) δ : 2.29(6H,s), 2.58(3H,s), 2.65(3H,s), 2.98(4H,t), 3.70(4H,t), 4.06(3H,s), 6.91(lH,d), 6.97(lH,s), 7.10(lH,t), 8.89(lH,s) Example 51 l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(2- methoxyphenyDpiperazine: Phenyl N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)carbamate and l-(2-methoxyphenyl)piperazine were reacted by the same way with the example 46 to obtain the titled compound. yield : 79% m.p. : 153-154 TJ 1H NMR(CDCb) δ : 2.58(3H,s), 2.65(3H,s), 3.15(4H,t ) , 3.73(4H.t ) , 3.90(3H.s). 4.06(3H,s), 6.91(lH,d), 6.96(lH,d), 6.97(lH,s). 7.10(lH,t). 8.89QH,s) Example 52 l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(3- hy droxyphenyl )piperazine: Phenyl N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)carbamate and l-(3-hydroxyphenyl)piperazine were reacted by the same way with the example 46 to obtain the titled compound. yield : 76% m.p. : oil phase l H NMR(CDCb) : 2.60(3H,s), 2.72(3H,s), 3.34(4H,t), 3.79(4H.t), 3.98(3H,s), 6.45(3H,m), 6.98(lH,m), 8.97(lH,s) Example 53 l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyl]-4-(3,5 -dimethoxyphenyDpiperazine: Phenyl N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)thiocarbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 22 to obtain the titled compound, δ yield : 77% m.p. : 167-1691C Η NMR(CDCb) S : 2.58(3H,s), 2.68(3H,s), 3.47(4H,t), 3.81 (6H,s), 4.05(3H.s), 4.36(4H,t), 6.42(3H,m), 7.49(lH,s), 9.05(lH,s) 0 Example 54 l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yI ) aminothiocarbonyl]-4-(3,δ -dimethylphenyDpiperazine: Phenyl N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl )thiocarbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with 5 the example 22 to obtain the titled compound. yield : 75% m.p. : 176-177t Η NMR(CDCb) δ : 2.34(6H,s), 2.58(3H,s), 2.68(3H,s), 3.48(4H,l), 4.06(3H,s), 4.43(4H,t), 7.05(3H,m), 7.52(lH,s), 9.04(lH.s) 0 Example 5δ l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyl]-4-(3- h y droxy phenyl )piperazine: Phenyl N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)thiocarbamate and 25 l -(3-hydroxyphenyl)piperazine were reacted by the same way with the example 22 to obtain the titled compound. yield : 71% m.p. : 114-115TC Η NMR(CDCb) 5 : 2.56(3H,s), 2.75(3H,s), 3.68(4H,t). 4.05(3H,s), 30 4.45(4H,t), 7.30(4H,m), 9.03(lH,s) Mass(EI) m/z : Calcd for C23H30N4O4S1 458.1987, found 458.2527 Example 56 l- { [5-(l-HydroxyethyI ) -2-methoxy-6-methylpyridin-3-yl]aminocarbonyl} 35 -4- (3,5-dimethoxyphenyl)piperazine: l-[ ( 5-Acetyl-2-methoxy-6-methylpyridin-3-yl ) aminocarbonyl]-4-(3,5- dimethoxyphenyl)piperazine(100mg, 0.23mmol) was dissolved in anhydrous ethanol(15ml) and NaBH4(8.66mg) was added. The reaction solution was stirred at room temperature for 2 hours. The mixture was concentrated under the reduced pressure to remove ethanol and purified by column chromatography (ethylacetate : hexane = 2:1) to obtain the titled compound, yield : 97% m.p. : 124-126°C Η NMR(CDCb) ^ : 1.48(3H,d), 2.42(3H,s), 3.27(4H,t), 3.69(4H,t), 3.79(6H,s), 3.99(3H,s), 5.03(lH,q), 6.09(lH,s), 6.15(2H,d), 6.90(lH,s), 8.46(lH,s) Mass(EI) m/z : Calcd for C22H30N4O5 430.2216, found 430.2265 Example 57 l-{[5-(l-Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]aminocarbonyI} -4-(3,5-dimethylphenyl)piperazine: l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminυcarbonyl]-4-(3,δ- dimethylphenyDpiperazine was reacted by the same way with the example 56 to obtain the titled compound. yield : 95% m.p. : 153-154°C Η NMR(CDCb) : 1.48(3H,d), 2.30(6H.s), 2.42(3H,s), 3.26(4H.t), 3.68(4H,t), 3.99(3H,s), 5.05(lH,q), 6.71 (2H,d ) , 6.96(lH,s), 8.46(lH,s) Mass(EI) m/z : Calcd for C22H30N4O3 398.2317, found 398.2343 Example 58 l-{[5-(l-Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]aminocarbonyl} -4- (2,3-dimethylphenyDpiperazine: l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl]aminocarbonyl]-4-(2,3- dimethylphenyDpiperazine was reacted by the same way with the example 56 to obtain the titled compound. yield : 96% m.p. : 100-102 * C 1H NMR(CDCb) δ : 1.47(3H,d), 1.59(3H,s), 2.25(3H,s), 2.28(3H,s), 2.43(3H,s), 2.93(4H,t), 3.66(4H,t), 3.99(3H.s ) , 5.05(lH,q), 6.93(3H.m), 7.11 (lH,m), 8.48(lH,s) Example 59 l-{[5-(l-Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]aminocarbonyl} -4-(3,5-difIuorophenyI)piρerazine: l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(3,5- difluorophenyDpiperazine was reacted by the same way with the example 56 to obtain the titled compound. yield : 97% m.p. : 184-186°C Η NMR(CDCb) <? •' 1.48(3H,d), 2.50(3H,s), 3.30(4H,t), 3.70(4H,t), 4.11 (3H,s), 5.06(lH,q), 6.33(lH,s), 6.42(2H,d), 6.92(lH,s). 8.54(lH.s) Example 60 l-{[5-(l-Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]aminocaι-bonyl) -4-(3,5-dichlorophenyl)piperazine: l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl3-4-(3,5- dichlorophenyDpiperazine was reacted by the same way with the example 56 to obtain the titled comixnmd. yield : 95% 0 .p. : 197-200 ' C Η NMR(CDCb) : 1.46(3H,d), 2.41(3H,s), 3.28(4H,t), 3.66(4H.t), 3.96(3H,s), 5.20(lH,q), 7.02(3H,m), 8.42(lH,s) Example 61 δ l-{[δ-(l-Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]aminocarbυnyl} -4- (2-methoxyphenyl)piperazine: l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(2- methoxyphenyDpiperazine was reacted by the same way with the example 56 to obtain the titled compound. 0 yield : 97% m.p. : 88-90T Η NMR(CDCb) ^ : 1.47(3H,d), 2.42(3H,s), 3.11(4H,t), 3.70(4H,t), 3.89(3H,s), 3.99(3H,s), 5.03(lH,q), 6.89(3H,m), 6.94(lH,s), 7.05(lH.m), 8.48(lH,s) 5 Example 62 1 - { [5- ( 1 -Hydroxyethy 1) -2-methoxy-6-methylpy ridin -3-y llaminocarbony 1 } -4 - ( 3-hydroxyphenyl)piperazine : l-[5-AcetyI-2-methoxy-6-methyIpyridin-3-yl)aminocarbonyl]-4-(3-hydro xy phenyl )piperazine was reacted by the same way with the example 56 to obtain the titled compound, yield : 87% m.p. : 194-196t J H NMR(CDCbU : 1.47(3H,d), 2.41(3H,s), 3.27(4H,t), 3.79(4H,t), 3.98(3H,s), 5.04(lH,q), 6.57(3H,m), 6.90(lH,s), 7.13(lH,t), 8.41(lH,s) Example 63 l-{[5-(l-Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]aminothio carbonyl } -4 - (3,5-dimethoxy pheny Dpiperazine- ' l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yI)aminothiocarbonyl]-4-(3,5 -dimethoxyphenyDpiperazine was reacted by the same way with the example 56 to obtain the titled compound. yield : 89% m.p. : 189- 1901 Η NMR(CDCb) 5 : 1.47(3H,d), 2.43(3H,s), 3.35(4H.t ) . 3.78(6H,s). 3.97(3H,s), 4.09(4H,t), 5.05(lH,q), 6.07(3H,m ) . 7.35 ( lH,s ) , 8.42(lH,s) Example 64 l -{[5-(l -Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]aminothiυ carbonyI}-4-(3,5-dimethylphenyl)piperazine: δ l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyl3-4-(3,5 -dimethylphenyDpiperazine was reacted by the same way with the example 56 to obtain the titled compound. yield : 88% m.p. : 170-172t 0 *H NMR(CDCb) 5 : 1.46(3H,d), 2.29(6H,s), 2.43(3H,s). 3.43(4H,t), 3.97(3H,s), 4.10(4H,t), 5.06(lH,q), 6.60(3H,m), 7.37(lH,s), 8.40(lH,s) Example 65 l-{[5-(l-Hydroxy-l-methylethyl)-2-methoxy-6-methylρyridin-3-yl] 5 aminocarbonyl}-4-(3,5-dimetlιoxyphenyl)piperazine: l-{ ( 5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(3,5- dimethoxyphenyl)piperazine(214mg, 0.50mmol) was dissolved in tetrahydrofuran(lθml) and CH3MgBr(0.50ml, l.δOmmol) was added slowly. The mixture solution was refluxed for 15 hrs and concentrated under the reduced pressure to remove the solvent and extracted with ethylacetate, dried and filtered. The resultant was purified by column chromatography (ethylacetate •' hexane = 1: 2) to obtain the titled compound, yield : 84% m.p. : 146-148 * 0 ] H NMR(CDCb) <5 : 1.64(6H,s), 2.64(3H,s), 3.25(4H,t), 3.67(4H,t). 3.78(6H.s). 3.99(3H,s), 6.07(3H,m), 6.86(lH,s), 8.47(lH,s) Example 66 l-{[5-(l-Hydroxy-l-methylethyl)-2-methoxy-6-methylpyridin-3-yl] aminocarbonyl}-4-(3,5-dimethylphenyl)piperazine: l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(3.5- dimethylphenyDpiperazine was reacted by the same way with the example 65 to obtain the titled compound. yield : 81% m.p. : oil phase Η NMR(CDCb) δ : 1.64(6H,s), 2.29(6H,s), 2.65(3H,s), 3.24(4H,t). 3.67(4H,t), 3.99(3H,s), 6.59(3H,m), 7.05(lH,s), 8.48(lH,s) Example 67 l-{[5-(l-Hydroxy-l-methylpropyl)-2-methoxy-6-methylpyridin-3-yl] aminocarbonyl } -4 - (3,5- dimethoxypheny 1 )piperazine: l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(3.5- dimethoxyphenyl)piperazine(214mg, 0.50mmol) was dissolved in tetrahydrofuran (10ml) and C2H5MgBr(0.50mg, l.δOmmol) was added slowly. The mixture solution was refluxed for 15 hours and concentrated under the reduced pressure to remove the solvent and extracted with ethylacetate, dried and filtered. The resultant was purified by column chromatography (ethylacetate : hexane = 1:2) to obtain the titled compound. yield : 76% m.p. : 127-1291C H NMR(CDCb) <? : 0.83(3H,t), 1.63(3H,s), 1.94(2H,m), 2.61 (3H.s), 3.26(4H,t), 3.68(4H,t), 3.79(6H,s), 3.99(3H,s), 6.08(3H,m), 6.86(lH.s), 8.44(lH,s) Example 68 l-{[5-(l-Hydroxy-l-methylpropyl)-2-methoxy-6-methylpyridin-3-yI] aminocarbonyl}-4-(3,5-dimethylphenyl)piperazine: l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(3,5- dimethylphenyDpiperazine was reacted by the same way with the example 67 to obtain the titled compound. yield : 74% m.p. : 164-165 °C Η NMR(CDCb) <ϊ : 0.83(3H,t), 1.60(3H,s), 1.95(2H,m), 2.29(6H,s), 2.61(3H,s), 3.23(4H,t), 3.67(4H,t), 3.99(3H,s), 6.59(3H,m), 6.87(lH,s), 8.45(lH,s) Example 69 l-[δ-({[4-(3,5-Dimethoxyphenyl)piperazino]carbonyUamino ) -6-methoxy-2 -methylpyridin-3-yl3ethyl ethanthioate: Triphenylphosphine(262mg, l.Ommol) was dissolved in tetrahydrofuran (15ml) and diethyl azodicarboxylate(157/x(\ l.Ommol) was added and then the mixture was stirred at 0 * C for 30min. l-{[5-(l-Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl3aminocarbonyl ) -4-(3,5-dimethoxyphenyl)piperazine(213mg, O.δmmol) and thioacetic acid(72μ(!, l.Ommol) were dissolved in tetraliydrofuran and was added into the above solution. The mixture solution was stirred at 0'C for lhour and at room temperature for lhour and then was concentrated under the reduced pressure to remove the solvent. The concentrate was purified by column chromatography (ethylacetate • ' hexane = 1:2) to obtain the titled compound, yield : 62% m.p. : oil phase 1H NMR(CDCb : 1.55(3H,d), 2.20(3H,s ) , 2.39(3H,s), 3.15(4H,t), 3.57(4H,t), 3.69(6H,s), 3.90(3H,s), 4.74(lH,q), 6.01(3H,m ) , 6.89(lH,s), 8.33(lH,s) Example 70 1 - [5- ( { [4- (3,5-Dimethylphenyl)piperazino3carbony 1 } amino ) -6- methoxy - 2 - methylpyridin-3-yl3ethyl ethanthioate: l-{[δ-(l-Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]aminocarbonyl} -4-(3,5-dimethylphenyl)piperazine was reacted by the same way with the example 69 to obtain the titled compound. yield : 60% m.p. •' oil phase Η NMR(CDCb) δ : 1.60(3H,d), 2.26(6H,s), 2.52(3H,s). 3.20(4H,t), 3.64(4H.t). 3.96(3H,s), 4.80(lH,q), 6.56(3H,m), 6.91 (lH,s), 8.38(lH,s) Example 71 l-([2-Methoxy-6-methyl-5-(l-sulfanylmethyl)3aminυcarbonyl}-4-(3,5- dimethoxyphenyDpiperazine: l-[δ-(([4-(3,5-Dimethoxyphenyl)piperazino]carbonyl)amino)-6-methoxy-2 -methylpyridin-3-yl]ethyl ethanthioate(180mg, 0.37mmol) was dissolved in tetrahydrofuran (15ml) and LiAlHaQδmg, 0.4mmol) was added and then the mixture was stirred at 0 * C for 20min. 2N-HC1 was added the above solution. The mixture was concentrated under the reduced pressure to remove the solvent and extracted with dichloromethane, dried and filtered. The resultant was concentrated under the reduced pressure and purified by column chromatography (ethylacetate hexane - 1:2) to obtain the titled compound, yield : 88% m.p. : oil phase Η NMR(CDCb) δ : 1.42(3H,d), 2.39(3H,s), 3.25(4H,t), 3.66(4H,t), 3.76(6H,s), 3.96(3H,s), 5.02(lH,q), 6.17(3H.m). 6.87(lH,s), 8.41(lH,s) Example 72 l-{[2-Methoxy-6-methyl-5-(l-sulfanylmethyl)3aminocarbonyl}-4-(3,δ- dimethy lpheny 1 )piperazine: l-[δ-({[4-(3,5-Dimethylphenyl)piperazino3carbonyl}amino)-6-methoxy-2- methylpyridin-3-yl3ethyl ethanthioate was reacted by the same way with the example 71 to obtain the titled compound. yield : 87% m.p. : oil phase 1H NMR(CDCb) δ : 1.43(3H,d), 2.28(6H,s), 2.40(3H,s), 3.2δ(4H,t), 3.72(4H,t), δ.03(lH,q), 6.64(3H,m), 6.88(lH,s), 8.42(lH,s) Exmaple 73 l-[(2-Methoxy-6-methyl-5-vinylpyridin-3-yl)aminocarbonyl]-4-(3,5- dimethoxyphenyDpiperazine: l-{[δ-(l-HydroxyethyI-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl) -4-(3,5-dimethoxyphenyl)piperazine was dissolved in chloroform (15ml) and pyridinum p-toluensulfonate(60mg, 0.23mmol) was added and then the mixture solution was refluxed 16hours. The above solution was concentrated under the reduced pressure to remove chloroform and purified by column chromatography to obtain the titled compound. yield : 93% m.p. : 140-141°C 1H NMR(CDCb) £ : 2.43(3H,s), 3.27(4H,t), 3.69(4H,t), 3.79(6H,s), 4.00(3H,s), 5.25(lH,d), 5.65QH,d), 6.08(lH,s), 6.13(2H,d), 6.82(lH,d), 6.91 (lH,s), 8.53(lH,s) Mass(EI) m/z : Calcd for C22H28N4O4 412.2110, found 412.2119 Example 74 l-[(2-Methoxy-6-methyl-5-vinylpyridin-3-yl)aminocarbonyl]-4-(3.δ- dimethylphenyOpiperazine: l-{[δ-(l-Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yI]aminocarbonyl) -4-(3,5-dimethylphenyl)piperazine was reacted by the same way with the example 73 to obtain the titled compound. yield : 94% m.p. : 131-132°C 1H NMR(CDCb) 5 : 1.57(3H,s), 2.31(6H,s), 2.43(lH,s), 3.25(4H,t), 3.68(4H,t), 4.00(3H,s), 5.25(lH,d), 5.65(lH,d) 6.60(3H,m), 6.82(lH,dd), 6.92(lH,s), 8.δ3(lH,s) Mass(EI) m/z : Calcd for C22H28N4O2 380.2212, found 380.2236 Example 75 l-[(2-Methoxy-6-methyl-δ-vinylpyridin-3-yl)aminocarbonyl]-4-(3,5- difluorophenyDpiperazine: l-{[5-(l-Hydroxyethyl ) -2-methoxy-6-methylpyridin-3-yl]aminocarbυnyl} -4-(3,5-difluorophenyl)piperazine was reacted by the same way with the example 73 to obtain the titled compound, yield : 93% m.p. : 160-161°C l H NMR(CDCb) : 2.44(3H,s), 3.30(4H,t,J=5.5Hz), 3.68(4H,tJ=5.5Hz), 4.01 (3H,s), 5.26(lH,d), 5.65(lH,d), 6.30(lH,s ) , 6.39(2H,d), 6.81(lH,dd), 8.53(lH,s) Mass (ED m/z : Calcd for C22H28N4O4 412.2110, found 412.2102 Example 76 l-[(5-Isopropenyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyI]-4- (3,δ-dimethoxyphenyI)piperazine: -{[δ-(l-Hydroxy-l-methylethyl)-2-methoxy-6-methylpyridin-3-yl) aminocarbonyl3)-4-(3,5-dimethoxyphenyl)piperazine was reacted by the same way with the example 73 to obtain the titled compound. yield : 96% m.p. : 83-85"C Η NMR(CDCb) <5 : 2.01 (3H,s), 2.38(3H,s). 3.25(4H,t), 3.66(4H,t), 3.78(6H,s), 3.99(3H,s), 4.86(lH,s), 5.30(lH,s), 6.11(3H,m), 6.90(lH.s), 8.18(lH,s) Example 77 l-[(5-Isopropenyl-2-methoxy-6-methylpyridin-3-yl ) aminocarbonyl]-4- (3,δ-dimethylphenyl)piperazine: l-{[δ-(l-Hydroxy-l-methylethyl)-2-methoxy-6-methylpyridin-3-yl]amin ocarbonyl}-4-(3,5-dimethylphenyl)piperazine was reacted by the same way with example 73 to obtain the titled compound. yield : 93% m.p. : 140-142'C l H NMR(CDCb) <5 : 2.01 (3H,s), 2.29(6H,s), 2.28(3H,s), 3.23(4H,t), 3.66(4H,t), 3.99(3H,s), 4.86(lH,s), 5.18(lH,s), 6.59(3H,m), 6.91(lH,s), 8.18(lH,s) Example 78 Ethyl 2-{l-[5-({[4-(3,δ-dimethoxyphenyl)piperazino]carbonyl}amino)-6- methoxy-2-methylpyridin-3-yl3ethoxy}acetate: 1 - f [5- ( 1 -Hydroxy )-2-methoxy-6-methylpyridin -3-y l]aminocarbonyl } -4- (3,5-dimethoxyphenyI)piperazine(0.5mmol) was dissolved in dimethylformamide(15ml) and NaH(18.5mg, O.δmmol) was added and then the mixture solution was stirred at room temperature for 15min. Ethylbromoacetate(83.5mg, O.δmmol) was added into the above mixture and stirred at room temperature for 3hours. The mixture was concentrated under the reduced pressure to remove the solvent and purified by column chromatography(ethylacetate •" hexane = 1:2) to obtain the titled compound. yield : 89% m.p. : oil phase 1H NMR(CDCb) δ : 1.25(3H,t), 1.34(3H,d), 2.42(3H,s), 3.00(4H,t), 3.29(4H,t), 3.74(6H,s), 3.97(3H,s), 4.16(4H,s), 4.53(lH,q), 6.03(3H,m), 7.58(lH,s) Example 79 4-{l-[5-({[4-(3,5-Dimethoxyphenyl)piperazino3carbonyl}aminυ)-6-methox y-2-methylpyridin-3-yl3ethoxy}-4-oxobutanoic acid: l-{[5-(l-Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]aminocarbonyl} -4-(3,5-dimethoxyphenyl)piperazine(107mg, 0.25mmol) and dimethylaminopyridine(3mg, 0.025mmol) were dissolved in pyridine and anhydrous succinic acid(δ0mg, O.δmmol) was added. The mixture was stirred at room temperature for δhrs. Distilled water was added into the above mixture. The above solution was extracted with CH2CI2 and the organic phase washed with IN-HCl and then concentrated under the reduced pressure to remove the solvent. The concentrate was purified by column chromatography (dichloromethane : methanol = 20:1) to obtain the titled compound. yield : 78% m.p. : 158-160'C 1H NMR(CDCb) <5 : 1.42(3H,d), 2.43(3H,s), 2.61(4H,m), 3.24(4H,t), 3.66(4H,t), 3.76(6H,s), 3.95(3H,s), 5.94(lH,q), 6.04(3H,m), 6.89(lH,s), 8.13(lH,s) Example 80 4-{l-[5-({[4-(3,5-Dimethylphenyl)piperazino]carbonyl}amino ) -6-methoxy- 2-methylpyridin-3-yl3ethoxy}-4-oxobutanoic acid: l-{[5-(l-hydiOxyethyl)-2-methoxy-6-methylpyridin-3-yl]aminocarbony]} -4-(3,5-dimethylphenyl)piperazine was reacted by the same way with the example 79 to obtain the titled compound. yield : 76% m.p. : 138- 140 "C Η NMR(CDCb) : 1.43(3H,d), 2.27(6H,s), 2.55(3H,s), 2.65(4H,m), 3.24(4H.t), 3.69(4H,l), 3.95(3H,s), 5.9δ(lH,q), 6.60(3H,m), 6.88(lH,s). 8.11 (lH.s) Example 81 l -[(2-Methoxyquinolin-3-yl)aminocarbυnyl]-4-(3.δ-dιmeth(jχyphen\ l ) piperazine: a) Phenyl N-(2-methoxyquinoiin-3-yI)carbamate: 3-Amino-2-methoxyquinoline(4g, 23mmol) and phenyl chlorofoπτιate(4.04g, 2δmmol) were dissolved in dichloromethane and stirred at room ten jerature for 2 hours. The above mixture w;ι^ concentrated under the reduced pressure to remove dichloromethane and purified by column chromatυgraphy(hexane : ether =8'1 ) m obtain the tilled compound, yield : 75% m.p. • oil phase 'I I NMR (CDCb): <S 4.0K3H.S), 7.30(5H.s), 7.4H1H.U. 7.70( lH.d ) . 7.71 UH.d). 8.71 (lH.s) b) 1 -[(2-Melhoxyquinolin-3-yl)aminocarbonyl]-4-(3,δ-dimethoxyphenyl ) piperazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate(148mg. O.δmmol) and l-(3,5-dimelhυxyphenyl)piperazine(112mκ, O.δmmυl) were dissolved in anhydrous tetrahydrofuran and DBU(117mg. 0.75mmυl ) was added. The solution was stirred at room temperature for 2 hours. The mixture was concentrated under the reduced pressure to remove tetrahydrofuran and purified by column chromatography (hexane : ether = 5: 1 ) to obtain the titled compound, vield : 81% m.p. : 200-201°C 1H NMR (CDCb): δ 3.31(4H,tJ=5.0Hz), 3.74(4H,t), 3.79(6H,s), 4.17(3H,s), 6.09(lH,s), 6.17(2H,s), 7.35(lH,t), 7.49(lH,t), 7.71(lH,d), 7.78(lH,d), 8.78(lH,s) Mass(EI) m/z : Calcd for C23H26N4O4 422.19δ4, found 422.19δ2 Example 82 l-[(2-Melhoxyquinolin-3-yl)aminocarbonyI]-4-(3,δ-dimethylphenyl) piperazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : 79% m.p. : 143-145°C Η NMR (CDCb): δ 2.30(6H,s), 3.29(4H,t), 3.80(4H,t), 4.18(3H,s), 6.62(3H,m), 7.36(lH,t), 7.49(lH,t), 7.71(lH,d), 7.78(lH,d), 8.79(lH,s) Mass(EI) m/z : Calcd for C23H26N4O2 390.20δ5, found 390.2066 Example 83 l-[(2-Methoxyquinolin-3-yl)aminocarbonyl3-4-(2,3-dimethyl]jhenyl) pijxirazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l -(2,3-dimethylphenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : 83% m.p. : 174-175'C Η NMR (CDCb): δ 2.20(3H,s), 2.39(3H,s), 3.28(4H,t), 3.69(4H.t), 3.93(3H,s), 5.98(lH,s), 6.30(lH,t), 6.37(lH,s), 6.39(lH,s), 6.63(lH.s) Example 84 l-[(2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(3,5-difluorophenyl) piperazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l-(3,5-difluorophenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. vield : 78% m.p. : 158-159X 'H NMR (CDCb): δ 3.32(4H,tJ=5.0Hz), 3.72(4H,t,J=5.0Hz), 4.19(3H,s), 6.29(lH,s), 6.39(2H,d), 7.36(lH,t), 7.50(lH,t), 7.71 (lH,d), 7.81 (lH.d), 8.78(lH,s) Example 85 l-[(2-Methoxyquinolin-3-yl)aminocarbonyl3-4-(3,5-dichlorophenyl) piperazine- ' Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l -(3,5-dichlorophenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : δ6% m.p. : 156-1581C Η NMR (CDCb): δ 3.33(4H,t), 3.73(4H,t), 4.21 (3H,s) 6.79(lH,s), 6.83(lH,d), 6.93(lH,t), 7.26(lH,t), 7.38(lH,t), 7.52(lH.t). 7.71 (lH,d), 7.R3QH,d) Mass(EI) m/z : Calcd for C21H20N4O2CI1 430.0963, found 430.0977 Example 86 l-[ ( 2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(2-fluorophenyl ) piperazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l-(2-fluorophenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : 81% m.p. : 156-158'C Η NMR (CDCb): δ 3.18(4H,t), 3.74(4H,t), 4.18(3H,s ) . 6.99 ( 2H,q), 7.07(2H,m), 7.35(2H,m), 7.50(lH,t), 7.70(lH,d), 7.77(lH,d ) Example 87 l~[(2-Methoxyquinolin-3-yl)aminocarbonyl3-4-(2-chlorophenyl)piperazine: Phenyl N-(2-methoxyquinoline-3-yl)carbamate and l-(2-chlorophenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : 78% m.p. : 79-80 V, 1H NMR (CDCb): δ 3.32(4H,t), 3.74(4H,t), 4.20(3H,s), 6.82(2H,q), 6.94(2H,m), 7.34(2H,m), 7.48(lH,d), 7.70(lH,d), 7.78(lH,d) Example 88 l-[(2-Methoxyquinolm-3-yl)aminocarbonyl3-4-(3-chlorophenyl)piperazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l-(3-chlorophenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound, yield : 73% m.p. : 97-98°C Η NMR (CDCb): δ 3.31(4H,t), 3.73(4H,t), 4.18(3H.s), 6.82(lH,d), 6.87(lH,d), 6.92(lH,s), 7.21(lH,t), 7.32(lH,s), 7.37(lH,t), 7.51(lH.t), 7.70(lH,d), 7.78(lH,d), 8.80(lH,s) Example 89 l-[(2-Methoxyquinolin-3-yl)aminocarbonyl3-4-(3-hydroxyphenyl) piperazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l-(3-hydroxyphenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : 7δ% m.p. : 190-191 °C 'II NMR (CDCb): <? 3.33(4H,t), 3.80(4H,t ) , 4.19(3H,s), 6.47(lH,s). 6.62(2H,s), 7.16(lH,t), 7.32(lH,s), 7.37(lH,t), 7.51 (lH.t), 7.72(lH,d), 7.78(lH,d), 8.78(lH,s) Example 90 l-[ ( 2-Methoxyquinolin-3-yI)aminocarbonyl3-4-(2-methoxyphenyl) piperazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l-(2-methoxyphenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : 88% m.p. : 159-161 'C 1H NMR (CDCb): δ 3.28(4H,t), 3.71(4H,t), 3.81(3H,s), 4.18(3H,s), 6.52(2H,s), 6.62(lH,s), 7.23(lH,t), 7.31-7.53(3H,m), 7.72(2H,m), 8.81(lH,s) Example 91 l-[(2-Methoxyquinolin-3-yl)aminocarbonyl3-4-(2-methylthiophenyl) piperazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l-(2-methylthiophenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : 78% m.p. : 147-149t Η NMR (CDCb): δ 2.44(3H,s), 3.07(4H,t), 3.75(4H,t), 4.18(3H.s), 7.13(3H,m), 7.18(lH,d), 7.39(2H,m), 7.70(3H,m), 8.81 (lH.s) Example 92 l-[(2-MethoxyquinoIin-3-yl)aminocarbonyl3-4-(3-isopropoxyphenyl) piperazine." Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l -(3-isopropoxyphenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : 93% m.p. : 111-113'C Η NMR (CDCb): δ 1.34(6H,d), 3.30(4H,t), 3.74(4H,t), 4.18(3H,s), 4.5δ(lH,m), 6.49(2H,s), 7.0δ(lH,s). 7.20(lH,t), 7.32(lH,s). 7.37(lH,t), 7.50(lH,t), 7.70(lH,d), 7.77(lH.d), 8.80(lH.s) Example 93 l-[(2-Methoxyquinolin-3-yl)aminocarbonyl3-4-(3-cyclopropylmethoxy phenyl )piperazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l-(3-cyclopropylmethoxyphenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : 90% m.p. : 146-147X: , 1H NMR (CDCb): δ 0.36(2H,t), 0.65(2H,m), 1.28(lH,m), 3.31 (4H,t), 3.7δ(4H,t), 3.80(2H,d), 4.18(3H,s), 6.δO(lH,s), 6.60(2H,s), 7.19(lH,t). 7.32QH,s), 7.37(lH,t), 7.50(lH,t), 7.70(lH,d), 7.77(lH,d), 8.79(lH.s) Example 94 1 - [ ( 2-Methoxyquinolin -3-y Daminocarbony 1] -4 - (2-methoxy-5-methy 1 phenyDpiperazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l-(2-methoxy-5-methylphenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : 76% m.p. : 115-116 C 1H NMR (CDCb)-' δ 2.30(3H,s), 3.14(4H,t), 3.75(4H,t), 3.87(3H,s), 4.18(3H,s), 6.79(2H,m), 6.84(lH,d), 7.35(2H,m), 7.δO(lH,t), 7.72(lH,d), 7.77(lH,d), 8.82(lH,s) Example 95 l-[(2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(2-methoxy-5-phenyl phenyl )piperazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l-(2-methoxy-δ-phenylphenyl)piperazine were reacted by the same way- with the example 81 to obtain the titled compound. yield : 77% m.p. : 122-123 Η NMR (CDCb): δ 3.38(4H.t ) 3.86(4H,t), 3.97(3H,s), 4.18(3H.s), 7.05(2H,m), 7.34-7.45(6H,m), 7.50(1H,D, 7.δ6(2H,d), 7.71 (2H.d), 7.78(2H,d), 8.88(lH,s) Example 96 l -[(2-Methoxyquinolin-3-yl)aminocarbonyl3-4-(δ-methoxy-2-methyl phenyDpiperazine: Phenyl N-{2-methoxyquinolin-3-yl)carbamate and l-(δ-methoxy-2-methylphenyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : 82% m.p. : 128-130 * 0 l H NMR (CDCb): δ 2.30(3H,s), 3.37(4H,t), 3.84(4H,t), 3.78(3H,s), 3.97(3H,s), 7.0δ(2H,m), 7.13(lH,d), 7.38(3H,m), 7.62(lH,d), 7.80(lH,s), 8.88(lH,s) Example 97 l-[(2-Methoxyquinolin-3-yl)aminocarbonyl3-4-(l-naphthyl)piperazine: Phenyl N-(2-methoxyquinolin-3-yl)carbamate and l-(l-naphthyl)piperazine were reacted by the same way with the example 81 to obtain the titled compound. yield : 68% m.p. : 158-1601C 1H NMR (CDCb): δ 3.22(4H,t), 3.86(4H,t), 4.20(3H,s), 7.13(lH,d), 7.38(2H,m), 7.43UH,t), 7.53(3H,m), 7.62(lH,d), 7.72(lH,d), 7.80(lH,d), 7.86(lH,d), 8.24(lH,d), 8.84(lH,s) Example 98 l-[N-(2-Methoxyquinolin-3-yl)-N-methylaminocarbonyl3-4-(3,5- dimethoxyphenyDpiperazine: l-[(2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(3,δ-dimethoxyphenyI) piperazine(106mg, 0.25mmol) was dissolved in dimethylformamide(lδml) and sodium hydride(6.0mg, 0.2δmmol) was added and the solution was stirred at room temperature for lδ min. Iodomethane(3δmg, 0.2δmmol ) was added to the above solution. The mixture was stirred at room temperature for 16 hours and concentrated under the reduced pressure to remove dimethylformamide. The concentrate was purified by column chromatography (ethylacetate : hexane = 1:2) to obtain the titled compound. yield : 93% m.p. : 88-89 'C Η NMR (CDCb): δ 2.93(4H,t), 3.17(3H,s), 3.34(4H,t), 3.72(6H.s). 4.15(3H,t), δ.9δ(2H,s), δ.98(lH,s), 7.40(lH,t), 7.61 (2H,m), 7.73(lH,s). 7.84(lH,d) Mass(EI) m/z : Calcd for C2 H28N O4 436.2110, found 436.2105 Example 99 l-[N-Ethyl-N-(2-methoxyquinolin-3-yl)aminocarbonyl]-4-(3,δ-dimethox ypheny 1 )piperazine: l-[(2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(3,5-dimethoxyphenyl) piperazine(106mg, 0.25mmol) was dissolved in dimethylformamide(15ml) and was sodium hydride(6.0mg, 0.2δmmol) was added and the solution was stirred at room temperature for lδ min. Iodoethane(3δmg, 0.2δmmol) was added to the above solution. The mixture was stirred at room temperature for lβhours and concentrated under the reduced pressure to remove dimethylformamide. The concentrate was purified by column chromatography (ethylacetate : hexane = 1:2) to obtain the titled δ compound, yield : 91% m.p. : 118-120 * 0 Η NMR (CDCb): δ 1.16(3H,t), 2.89(4H,t), 3.30(4H,t), 3.63(2H,m), 3.71(6H,s), 4.13(3H,s), 5.93(2H,s), δ.98(lH,s), 7.41(lH,t), 7.60(lH,t), 0 7.66(lH,d), 7.71(lH,s), 7.84(lH,d) Mass(EI) m/z : Calcd for C25H30N4O4 4δ0.2227, found 4δ0.2206 Example 100 1 -[N-Isopropyl-N-(2-methoxyquinohn-3-yl)aminocarbonyl]-4- (3,5- 5 dimethoxyphenyDphenyl: l-[(2-Methoxyquinoiin-3-yl)aminocarbonyl]-4-(3,5-dimethoxyphenyl) piperazine(106mg, 0.2δmmol) was dissolved in dimethylfor arnide(lδrnl) and sodium hydride(6.0mg, 0.2δmmol) was added and the reaction solution was stirred at room temperature for Iδ min. 0 2-Propyliodide(42mg, 0.2δmmol) was added to the above solution. The mixture was stirred at room temperature for 16 hours and concentrated under the reduced pressure to remove the dimethylformamide. The concentrate was purified by column chromatography(ethylacetate : hexane = 1:2) to obtain the titled compound. 5 yield : 87% m.p. : 123-125 * 0 Η NMR (CDCb): δ 1.21 (6H,d), 2.79(4H,t), 3.29(4H,t). 3.70(6H.s), 4.08(3H,s), 4.41(lH,m), 5.90(2H,s), 5.96(lH,s), 7.43(lH,t), 7.63(lH,t), 7.69(lH,d), 7.75(lH,s), 7.83QH,d) 30 Example 101 l-[N-Cyclopropylmethyl-N-(2-methoxyquinolin-3-yl)aminocarbonyl]-4- (3,δ-dimethoxyphenyl)piperazine: l-[(2-methoxyquinolin-3-yl)aminocarbonyl]-4-(3,δ-dimethoxyphenyl) 35 piperazine(106mg, 0.2δmmol) was dissolved in dimethylformamide(lδml) and sodium hydride(6.2mg, 0.26mmol) was added and the solution was stirred at room temperature for 15 min. Bromomethylcyclopropane(22mg, 0.26mmol) was added to the above solution. The mixture was stirred at room temperature for 16 hours and concentrated under the reduced pressure to remove dimethylformamide. The concentrate was purified by column chromatography (ethylacetate •' hexane = 1:2) to obtain the titled compound, yield : 78% m.p. : 118-1201 Η NMR (CDCb): δ 0.41(2H,m), 0.85(2H,m), 1.28(lH,m), 2.88(4H.t), 3.24(4H,t), 3.42(2H,d), 3.71(6H,s), 4.13(3H,s), 5.94(3H,s), 7.44(lH,d), 7.62(lH,d), 7.78(3H,m) Example 102 l -[N-Benzyl-N-(2-methoxyquinolin-3-yl)aminocarbonyl]-4-(3,δ- dimethoxyphenyDpiperazine: l-[(2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(3,5-dimethoxyphenyl) • piperazine(114mg, 0.27mmol) was dissolved in dimethylfoιτnamide(15ml ) and sodium hydride(6.6mg, 0.27mmol) was added and the solution was stirred at room temperature for lδ min. Benzylbromide(46mg, 0.27mmol ) was added to the above solution. The mixture was stirred at room temperature for 16 hours and concentrated under the reduced pressure to remove dimethylformamide. The concentrate was purified by column chromatography (ethylacetate : hexane = 1:2) to obtain the titled compound. yield : 90% m.p. : oil phase Η NMR (CDCb): δ 2.92(4H,t), 3.39(4H,t), 3.72(6H,s). 4.13(3H,s), 4.79(2H,s), 6.01 (3H,m), 7.21(lH,m), 7.25(2H,m), 7.33(3H,m), 7.51(lH,s), 7.57(2H,m), 7.81(2H,d) Example 103 l-[N-(2-Methoxyquinolin-3-yl)-N-methylaminocarbonyl]-4-(3,5-dimethyl phenyDpiperazine: l-[(2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(3.5-dimethylphenyl) piperazine was reacted by the same way with the example 98 to obtain the titled compound. yield : 92% m.p : 142-143 "C 1H NMR (CDCb): δ 2.27(6H,d), 2.90(4H,t), 3.17(3H,s), 3.34(4H,t), 4.1δ(3H,s), 6.41(2H,s), 6.49(lH,s), 7.40(lH,t), 7.63(lH,t), 7.6δ(lH,d), 5 7.73(lH,s), 7.84(lH,d) Mass (ED m/z ■ ' Calcd for C2 H28N4O2 404.2212, found 404.2225 Example 104 l-[N-Ethyl-N-(2-methoxyquinolin-3-yl)aminocarbonyl]-4-(3,5-dimethyl j 0 phenyDpiperazine-' l-[(2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(3,5-dimethylphenyl) piperazine was reacted by the same way with the example 99 to obtain the titled compound. yield : 89% 15 m.p. : 84-86'C Η NMR (CDCb)-' δ 1.16(3H,t), 2.21(6H,s), 2.87(4H,t), 3.30(4H.t), 3.64(2H,q), 4.13(3H,t), 6.40(2H,s), 6.48(lH,s), 7.40(lH,t), 7.62(lH,t), 7.66(lH,d), 7.71 (lH,s), 7.84(lH,d) Example 105 l-[N-IsopropyI-N-(2-methoxyquinolin-3-yl)aminocarbonyl]-4-(3,5- dimethylphenyDpiperazine: l-[(2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(3,5-dimethylphenyl) piperazine was reacted by the same way with the example 100 to γ- obtain the titled compound. yield -' 84% m.p. : 114-115 * 0 Η NMR (CDCb): δ 1.21(6H,d), 2.20(6H,s), 2.77(4H,t), 3.28(4H,t), 4.08(3H,s), 4.39(lH,m), 6.37(2H,s), 6.46(lH,s), 7.41(lH,t), 7.63(lH,t), 30 7.69(lH,d), 7.75(lH,s), 7.83(lH,d) Example 106 l-[N-Benzyl-N-(2-methoxyquinolin-3-yl)aminocarbonyl]-4-(3,5- di ethylphenyDpiperazine: ,r l-[(2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(3,5-dimethylphenyl) piperazine was reacted by the same way with the example 102 to obtain the titled compound, yield : 90% m.p. : oil phase 1H NMR (CDCb): δ 2.24(6H,s), 2.87(4H,t), 3.31 (4H,t), 4.13(3H,s), 4.80(2H,s), 6.42(3H,s), 7.49(lH,t), 7.62(2H,m), 7.72(2H,m) Example 107 l-[N-(2-Methoxyquinolin-3-yl)-N-methylaminocarbonyl]-4-(3- isopropoxyphenyDpiperazine: l-[(2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(3-isopropoxyphenyl) piperazine was reacted by the same way with the example 98 to obtain the titled compound. yield : 92% m.p. : oil phase 'l-l NMR (CDCb): δ 1.28(6H,d), 2.97(4H,t), 3.18(3H,s), 3.37(4H,t), 4.14(3H,s), 4.49(lH,m), 6.41 (3H, ), 7.13(lH,m), 7.40(lH,t), 7.62(lH,t), 7.66(lH,d), 7.74(lH,s), 7.84(lH,d) Example 108 l-[N-Ethyl-N-(2-methoxyquinolin-3-yl)aminocarbonyl]-4-(3- i s υpropoxy pheny piperazine: l -[(2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(3-isopropoxyphenyl) jjiperazine was reacted by the same way with the example 99 to obtain the titled compound. yield : 87% m.p. : oil phase Η NMR (CDCb): δ 1.16(3H,t), 1.34(6H,d), 2.89(4H,t), 3.30(4H,t), 3.63(2H,m), 4.13(3H,s), 4.55(lH,m), 6.49(2H,s), 7.05(lH,s), 7.20(lH,t), 7.32(lH,s), 7.37(lH,t), 7.50(lH,t), 7.70(lH,d), 7.77(lH,d), 8.80(lH,s) Example 109 l-[(2-Methoxyquinolin-3-yl)aminothiocarbonyl]-4-(3,5-dimethoxyphenyl) piperazine: Phenyl N-(2-methoxyquinolin-3-yl)thiocarbamate(δ6mg, O.δmmol) and l-(3,δ-dimethoxyphenyl)piperazine(lllmg, O.δmmol ) were dissolved in anhydrous tetrahydrofuran and DBU(117rng, 0.75mmol) was added. The reaction solution was stirred at room temperature for 2 hours. The above solution was concentrated under the reduced pressure to remove tetrahydrofuran and concentrated was purified by column chromatography (Hexane •' ether = δ-'l) to obtain the titled compound. yield : 76% m.p. : 171-172TC Η NMR (CDCb): δ 3.41(4H,t), 3.81 (6H,s), 4.17(3H,s). 4.21 (4H,t), 6.12(lH,s), 6.20(lH,d), 7.38(lH,t), 7.54(lH,t), 7.74(lH,d), 7.81 (lH.d), 8.96(lH,s) Example 110 l-[(2-Methoxyquinolin-3-yl)aminothiocarbonyl]-4-(3,δ-dimethyljjhenyl) piperazine: Phenyl N-(2-methoxyquinohn-3-yl)thiocarbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 109 to obtain the titled compound. yield : 79% m.p. : 170-1711C 1H NMR (CDCb): δ 2.30(6H,s), 3.38(4H,t), 4.09(3H,s), 4.17(4H,t). 6.63(3H,m), 7.38(lH,t), 7.54(lH,t), 7.72(lH,d), 7.81(lH.d), 8.96(lH,s) Example 111 l-[(2-Methoxyquinolin-3-yDaminothiocarbonyI]-4-(3,5-difluorophenyl) piperazine: Phenyl N-(2-methoxyquinolin-3-yl)thiocarbamate and l-(3,δ-difluorophenyl)piperazine were reacted by the same way with the example 109 to obtain the titled compound. yield : 78% m.p. : 140-142 * C Η NMR (CDCb): δ 3.44(4H,t), 4.20(4H,t), 4.25(3H,s), 6.33(2H,m). 6.45(lH,d), 7.41(lH,t), 7.δ6(lH,m), 7.72(lH,m), 7.97(lH,m), 8.96(lH,s) Example 112 l-[(2-Methoxyquinolin-3-yl)aminothiocarbonyl]-4-(3,δ-dichlorophenyl) piperazine: Phenyl N-(2-methoxyquinolin-3-yl)thiocarbamate and l-(3,5-dichlorophenyl)piperazine were reacted by the same way with the example 109 to obtain the titled compound, yield : 62% m.p.: 181-183 * 0 5 Η NMR (CDCb): δ 3.44(4H,t), 4.20(4H,t), 4.26(3H,s), 6.77(lH,s), 6.88(2H,t), 7.41(lH,t), 7.59(lH,t), 7.70(2H,m), 8.01(lH,t), 8.11(lH t s), 8.93(lH,s) Example 113 o 1 -[(2-Methoxyquinolin-3-yl)aminothiocarbony l]-4- (3-methoxyphenyl ) piperazine: Phenyl N-(2-methoxyquinolin-3-yl)thiocarbamate and l-(3-methoxyphenyl)piperazine were reacted by the same way with the example 109 to obtain the titled compound. 5 yield : 81% m.p. : oil phase l H NMR (CDCb)-' δ 3.17(4H,t), 3.89(3H,s), 4.17(4H,t), 6.90(4H.m), 7.34(lH,t), 7.48(lH,t), 7.70(lH,d), 7.77(lH,d), 8.80(lH,s) 0 Example 114 l-[(2-Methylquinolin-3-yl)aminocarbonyI]-4-(3,5-dimethoxyphenyl ) piperazine: a) Phenyl N-(2-methylquinolin-3-yl)carbamate: 5 3-amino-2-methylquinoline(4g, 25mmol) and phenyl chloroformate(4.04g, 2δmmol) were dissolved in methylene chloride and then was stirred at room temperature for 2 hrs. The mixture solution was concentrated under the reduced pressure to remove methylene chloride and purified by column chromatography (ethylacetate : hexane = 1:10) to obtain the 30 titled compound, yield : 88% Η NMR (CDCb): δ 2.77(3H,s), 7.30-7.53(9H,m). 8.67(lH,s ) b ) l-[(2-Methylquinolin-3-yl ) aminocarbonyl]-4-(3,5-dimethoxyphenyl ) 3 piperazine: Phenyl N-(2-methylquinolin-3-yl)carbamate(140mg, O.δmmol) and l-(3,δ-dimethoxyphenyl)piperazine(112mg, O.δmmol) were dissolved in tetrahydrofuran and DBU(117mg, 0.75mmol) was added and then the mixture was stirred at room temperature for 2 hrs. The above solution was concentrated under the reduced pressure to remove tetrahydrofuran and purified by column chromatography (ethylacetate : hexane = 1:2) to obtain the titled compound, yield : 84% m.p. : 199-200 * C Η NMR (CDCb): δ 2.81 (3H,s), 3.30(4H,t), 3.76(4H,t), 3.80(6H.s), 6.08(lH,s), 6.12(2H,d), 7.48(lH,t), 7.62(lH,t), 7.71(lH,d), 8.03(lH,d). 8.59(lH,s) Example 115 l-[(2-Methylquinolin-3-yl)aminocarbonyl]-4-(3,5-dimethylphenyl) piperazine-' Phenyl N-(2-methylquinolin-3-yl)carbamate and l-(3,δ-dimethylphenyl)piperazine were reacted by the same way with the example 114 to obtain the titled compound. yield : 86% m.p. : 230-232 * C Η NMR (CDCb): δ 2.31 (6H,s), 2.82(3H,s), 3.29(4H,t), 3.76(4H.t), 6.60(3H,s), 7.49(lH,t), 7.63(lH,t), 7.73(lH,d), 8.05(lH.d ) , 8.61(lH,s ) Example 116 l-[(2-methylquinolin-3-yl)aminocarbonyl]-4-(2,3-dimethylphenyl) piperazine: Phenyl N-(2-methylquinolin-3-yl)carbamate and l-(2,3-dimethylphenyl)piperazine were reacted by the same way with the example 114 to obtain the titled compound. yield : 81% m.p. : 169-170'C 1H NMR (CDCb): δ 2.28(6H,d), 2.84(3H,s), 3.00(4H,t), 3.76(4H,t), 6.94(2H,m), 7.11(lH,t), 7.49(lH,t), 7.63(lH,t), 7.72(lH,d), 8.07(lH,d), 8.64UH,s) Example 117 l-[(2-Methoxyquinolin-3-yl)aminocarbonyl]-4-(3,δ-dϊfluorophenyl) piperazine: Phenyl N-(2-methylquinolin-3-yl)carbamate and l-(3,5-difluorophenyl)piperazine were reacted by the same way with the example 114 to obtain the titled compound. yield : 81% m.p. : 238-240 * C l H NMR (CDCb): δ 2.81(3H,t), 3.34(4H,t), 3.77(4H,t), 6.32(lH,t), 6.39(2H,d), 7.49(lH,t), 7.63(lH,t), 7.72(lH,d), 8.03(lH,d), 8.58(lH,s) Example 118 l-[(2-Methylquinolin-3-yl)aminocarbonyl]-4-(3,δ-dichlorophenyl) piperazine: Phenyl N-(2-methylquinolin-3-yl)carbamate and l-(3,δ-dichlorophenyl)piperazine were reacted by the same way with the example 114 to obtain the titled compound. yield : 6δ% m.p. : 247-249 * C Η NMR (CDCb): δ 2.79(3H,s), 3.33(4H,t), 3.7δ(4H,t). 6.78(2H,s), 6.87(lH,s), 7.49(lH,t), 7.63(lH,t), 7.72(lH,d), 8.δ6(lH,sJ Example 119 l-[(2-MethylquinoUn-3-yl)aminocarbonyl]-4-(2-methoxyphenyl) piperazine-' Phenyl N-(2-methylquinolin-3-yl)carbamate and l-(2-methoxyphenyl)piperazine were reacted by the same way with the example 114 to obtain the titled compound, yield : 83% m.p. : 135-136 * C Η NMR (CDCb):. δ 2.82(3H,s), 3.18(4H,t), 3.79(4H.t), 3.91 (3H.s), 6.88(lH,d), 6.97(2H,s), 7.07(lH,m), 7.48(lH,t), 7.62(lH,t), 7.72(lH,d), 8.04(lH,d), 8.63(lH,s) Example 120 l-[(2-Methylquinolin-3-yl)aminocarbonyl]-4-(2-fluorophenyl)piperazine: Phenyl N-(2-methylquinolin-3-yl)carbamate and l-(2-fluorophenyl)piperazine were reacted by the same way with the example 114 to obtain the titled compound, yield : 84% m.p. : 201-203 * C 1H NMR (CDCb): δ 2.84(3H,s), 3.20(4H,t), 3.80(4H,t), 6.99(2H,m), 7.07(2H,m), 7.49(lH,t), 7.62(lH,t), 7.71 (lH.d), 8.04(lH,d), 8.62(lH,s) Example 121 l-[(2-Methylquinolin-3-yl)aminocarbonyl]-4-(2-chlorophenyl)piιx;razine: Phenyl N-(2-methylquinolin-3-yl)carbamate and l-(2-chlorophenyl)piperazine were reacted by the same way with the example 114 to obtain the titled compound. yield : 72% m.p. : 180-181 * C 1H NMR (CDCb): δ 2.83(3H,s), 3.16(4H,t), 3.80(4H,t), 7.04(3H,m), 7.40(lH,d), 7.49(lH,t), 7.63(lH,t), 7.71(lH,d), 8.05(lH,d). 8.62(lH,s) Example 122 l-[(2-Methylquinolin-3-yl)aminocarbonyl]-4-(2-methylthiophenyI) piperazine- ' Phenyl N-(2-methylquinolin-3-yl)carbamale and l-(2-methylthiophenyl)piperazine were reacted by the same way with the example 114 to obtain the titled compound. yield : 76% m.p. : 165-166 * C Η NMR (CDCb): δ 2.45(3H,s), 2.85(3H,s), 3.11(4H,t), 3.79(4H,t), 7.05(lH,m), 7.1δ(3H,d), 7.49(lH,t), 7.63(lH,t), 7.69(lH,d), 8.07(lH,d), 8.62(lH,s) Example 123 l-[(2-Methylquinolin-3-yl)aminocarbonyl]-4-(2-methoxy-δ-methyl phen yDpiperazine : Phenyl N-(2-methylquinolin-3-yl)carbamate and l-(2-methoxy-δ-methylphenyl)piperazine were reacted by the same way with the example 114 to obtain the titled compound. yield : 80% m.p. : oil phase 1H NMR (CDCb): δ 2.30(3H,s), 2.72(3H,s), 3.17(4H,t), 3.70(4H,t), 3.87(3H,s), 6.77(lH,s), 6.82(2H,s), 7.73(4H,m), 8.60(lH,s) δ Example 124 1 - [ (2-Methylquinolin-3-y 1 )aminocarbony 1] -4 - ( 1 -naphthy Dpiperazine: Phenyl N-(2-methylquinolin-3-yl)carbamate and l-(l-naphthyl)piperazine were reacted by the same way with the 0 example 114 to obtain the titled compound. yield : 64% m.p. : 220-222 * 0 Η NMR (CDCb): δ 2.83(3H,s), 3.23(4H,t), 3.80(4H,t), 6.91(lH,s), 7.12(lH,d), 7.44(lH,d), 7.δO(3H,m), 7.61 (2H,m), 7.73(lH,d), 7.86(lH,d), 5 8.0δ(lH,d), 8.23(lH,d), 8.64(lH,s) Example 12δ l-[(2-Methylquinolin-3-yl)aminothiocarbonyl]-4-(3,δ-dimethoxyphenyl) piperazine: 0 a ) Phenyl N-(2-methylquinolin-3-yl)thiocarbamate: 3-Amino-2-methylquinoline(4g, 2δmmol) and phenyl chlorothionoformate(4.32g, 2δmmol) were dissolved in methylene chloride and then was stirred at room temperature for 2hours. The mixture 5 solution was concentrated under reduced pressure to remove methylene chloride and purified by column chromatography(ethylacetate : hexane - 1 : 2) to obtain the titled compound. yield : 78% 1H NMR (CDCb): δ 2.77(3H,s), 7.09-7.90(9H,m), 9.14(lH,s) 30 b) l-[(2-Methylquinolin-3-yl)aminothiocarbonyl]-4-(3,5-dimethoxyphenyl) piperazine: Phenyl N-(2-methylquinolin-3-yl)thiocarbamate(147mg, O.δmmol) and 5 l-(3,5-dimethoxyphenyl)piperazine(112mg, O.δmmol) were dissolved in anhydrous tetrahydrofuran and DBU(117mg. 0.7δmmol) was added and then the mixture was stirred at room temperature for 2 hrs. The above solution was concentrated under the reduced pressure to remove tetrahydrofuran and purified by column chromatography (ethylacetate : hexane = 1 : 2) to obtain the titled compound. yield : 86% m.p. : 211-212 * 0 Η NMR (CDCb): δ 2.81 (3H,s), 3.35(4H,t), 3.79(6H,s), 4.14(4H,t), 6.07(3H,s), 7.49(2H,t), 7.68(2H,m), 8.01 (lH.s), 8.07(lH,d) Example 126 l-[(2-Methylquinolin-3-yl)aminothiocarbonyl]-4-(3,δ-dimethylphenyl) piperazine: Phenyl N-(2-methylquinolin-3-yl)thiocarbamate and l-(3,δ-dimethylphenyl)piperazine were reacted by the same way with the example 125 to obtain the titled compound. yield : 81% m.p. : 196-197TC 1H NMR (CDCb): δ 2.27(6H,s), 2.81 (3H,s), 3.31(4H,t), 4.11(4H,t), 6.53(2H,s), 6.58(lH,s), 7.48(2H,t), 7.67(2H,m), 7.96(lH,s), 8.04(lH,d) Example 127 l-[(2-Methylquinolin-3-yl)aminothiocarbonyl]-4-(3,δ-difluυrophenyl ) piperazine: Phenyl N-(2-methylquinolin-3-yl)thiocarbamate and l-(3,δ-difluorophenyl)piperazine were reacted by the same way with the example 12δ to obtain the titled compound. yield : 74% m.p. : 211-213 * 0 1H NMR (CDCb): δ 2.85(3H,s), 3.43(4H,t), 4.22(4H,t), 6.33(2H,m), 7.49(lH,t), 7.64(lH,d), 7.72(lH,t), 8.16(2H,m) Example 128 l-{[2-(Pyridin-2-yl)quinolin-4-yl]aminocarbonyl}-4-(3,5- dimethoxyphenyDpiperazine: Phenyl N-[2-(pyridin-3-yDquinolin-4-yl]carbamate(171mg, O.δmmol) and l-(3,δ-dimethoxyphenyl)piperazine(lllmg, ' O.δmmol) were dissolved in anhydrous tetrahydrofuran and DBU(117mg, 0.75mmol) was added and then the mixture was stirred at room temperature for 2hrs. The above solution was concentrated under the reduced pressure to remove tetrahydrofuran and purified by column chromatography (dichloromethane : methanol=20:l) to obtain the titled compound, yield •' 73% m.p. : 97-98 * 0 Η NMR (CDCb): δ 3.34(4H,t), 3.79(6H,s), 3.90(4H,t), 6.07(lH,s), 6.12(2H,s), 7.43(lH,t), 7.δO(lH,t), 7.68(lH,t), 7.93(lH,t), 8.26(lH,d), 8.69(lH,d), 8.80(lH,d), 8.98(lH,s) Mass(EI) m/z : Calcd for C31H27N5O3 517.2113, found 517.3244 Example 129 l-{[2-(Pyridin-3-yl)quinolin-4-yl]aminocarbonyl)-4-(3,5- dimethoxyphenyDpiperazine: Phenyl N-[2-pyridin-3-yl)quinolin-4-yl]carbamate(171mg, O.δmmol) and l-(3,5-dimethoxyphenyl)piperazine(lllmg, O.δmmol) were dissolved in anhydrous tetrahydrofuran and DBU(117mg, 0.7δmmol) was added and then the mixture was stirred at room temperature for 2 hours. The above solution was concentrated under the reduced pressure to remove tetrahydrofuran and purified by column chromatography (dichloromethane : methanol = 20:1) to obtain the titled compound, yield : 67% m.p. : 95-96 * 0 Η NMR (CDCb): δ 3.36(4H,t), 3.87(6H,s), 3.90(4H,t), 6.08(lH.s). 6.12(2H,s), 7.50(lH,t), 7.71 (lH.t), 7.93(lH,t), 8.25(lH,d), 8.53(lH,d), 8.67(lH,s), 8.73QH,d), 9.35(lH,s) Example 130 l-{[2-Thien-2-yl)quinolin-4-yl]aminocarbonyl}-4-(3,5-dimethox\'phenyl) piperazine: Phenyl N-[2-(thien-2-yl)quinolin-4-yl]carbamate(173mg, O.δmmol) and l-(3.5-dimethoxyphenyl)piperazine(lllmg, O.δmmol) were dissolved in anhydrous tetrahydrofuran and DBU(117mg, 0.7δmmol ) was added. The resulting mixture was stirred at room temperature for 2 hours, concentrated under the reduced pressure to remove tetrahydrofuran and purified by column chromatography (ethylaetate : hexane = 1:1) to obtain the titled compound, yield : 61% m.p. : oil phase l H NMR (CDCb): 5 3.37(4H,t), 3.59(6H,s), 3.97(4H,t). 7.01 (3H,m), 7.49(lH,t), 7.69(lH,t), 7.93(lH,t), 8.20(lH,d), 8.52(lH,d), 8.64(lH,s), 8.71 (lH,d), 9.35(lH,s) Example 131 l-{[2-(Pyridin-3-yl)quinolin-4-yl]aminocarbonyl}-4-(3,5-dimethylphenyl) piperazine-' Phenyl N-[2-(pyridin-3-yl)quinolin-4-yl]carbamate(171mg, O.Smmol) and l-(3,δ-dimethylphenyl)piperazine(9δmg, O.δmmol) were dissolved in anhydrous tetrahydrofuran and DBU(117mg, 0.7δmmol) was added. The resulting mixture was stirred at room temperature for 2 hours, concentrated under the reduced pressure to remove tetrahydrofuran, and purified by column chromatography (ethylacetate •' hexane =1:1 ) to obtain the titled compound. yield : 64% m.p. : 211 -213 * 0 ] H NMR (CDCb): δ 2.31 (6H,s), 3.32(4H,t), 3.8δ(4H,t), 6.61 (3H.s). 7.47(lH,t), 7.δδ(lH,t), 7.72(lH,t), 7.86(lH,t), 8.25(lH,d), 8.53QH.d). 8.66(lH,s), 8.72(lH,d), 9.37(lH,s) Example 132 l-[N-(5,6-Dimethyl-2-methoxypyridin-3-yl)-N-methylamin(x;arbonyl]-4- (3,δ-dimethoxyphenyl)piperazine: l-[(δ,6-Dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4-(3,δ- dimethoxyphenyDpiperazinedOOmg, 0.2δmmol) was dissolved in dimethylformamidedδml) and thereto sodium hydride(6.0mg, 0.25mmol) was added. The resulting mixture was stirred at room temperature for 15 min and thereto iodomethane(35mg, 0.2δmmol) was added. The resulting mixture was stirred at room temperature for 16 hrs, concentrated under the reduced press sure to remove dimethylformamide, and purified by column chromatography(ethylacetate : hexane=l:2) to obtain the titled compound. yield : 94% m.p. : oil phase 1H NMR(CDCb) : 2.17(3H,s), 2.38(3H,s), 2.92(4H,t), 3.04(3H,s), 3.29(4H,t), 3.74(6H,s), 3.96(3H,s), 6.00(3H,m), 7.08(lH,s) δ Example 133 l-[N-Ethyl-N-(5,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyI]-4- (3,5 -dimethoxyphenyDpiperazine: l -[(δ,6-Dimethyl-2-methoxypyridin-3-yDaminocarbonyl]-4-(3,δ- 0 dimethoxyphenyDpiperazinedOOmg, 0.2δmmol) was dissolved in dimethylformamidedδml) and thereto sodium hydride(6.0mg, 0.2δmmol) was added, followed by stirring at room temperature for lδ min and then iodoethane(39.2mg, 0.2δmmol) was added. The resulting mixture was stirred at room temperature for 16 hrs, concentrated under the 5 reduced pressure to remove dimethylformamide, and purified by column chromatography (ethylacetate : hexane=l:2) to obtain the titled compound. yield : 86% m.p. : oil phase Η NMR(CDCb) r5 : 1.08(3H,t), 2.04(3H,s), 2.38(3H,s). 2.90(4H.t). 0 3.26(4H,t). 3.52(2H,q), 3.74(6H,s), δ.99(3H,m), 7.06(lH.s) Example 134 l-[N-lsopiOpyl-N-(δ,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]- 4 - (3,δ-dimethoxyphenyl)piperazine: 25 l-[(δ,6-Dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4-(3,δ- dimethoxyphenyDpiperazinedOOmg, 0.25mmol) was dissolved in dimethylformamidedδml) and thereto sodium hydride(6.0mg. 0.2δmmol) was added, followed by stirring at room temperature for 15 min, and then 2-iodopropane(42mg, 0.25mmol) was added. The resulting mixture 0 was stirred at room temperature for 16 hrs, concentrated under the reduced pressure .to remove dimethylformamide, purified by column chromatography (ethylacetate : hexane=l:2) to obtain the titled compound, yield : 78% m.p. : oil phase 35 1H NMR(CDCb) δ : 1.13(6H,d), 2.19(3H,s), 2.38(3H,s ) , 2.82(4H,t), 3.26(4H,t), 3.74(6H,s), 3.89(3H,s), 4.27dH,m), 6.06(lH,s), 6.10(2H.d). 7.07(lH,s), 8.14(lH,s) Mass(EI) m/z ■' Calcd for C24H3 N4O4 442.2580, found 442.2538 Example 135 1 -[N-(5,6-Dimethyl-2-methoxypyridin-3-yl)-N-methylaminocarbonyl]-4- (3,6- dimethy lphenyDpiperazine: l-[(δ,6-Dimethyl-2-methoxypyτidin-3-yl)aminocarbonyl]-4-(3,δ-dimethyl phenyDpiperazine was reacted by the same way with the example 132 to obtain the titled compound. yield : 97% m.p. •' oil phase Η NMR(CDCb) δ : 2.15(6H,s), 2.23(3H,s), 2.37(3H,s), 2.89(4H.t), 3.04(3H,s), 3.30(4H,t), 3.97(3H,s), 6.46(3H,m), 7.08(lH.s) Example 136 l-[N-(δ,6-Dimethyl-2-methoxypyridin-3-yl ) -N-methylaminocarbonyl]-4- ( 2-methoxyphenyl)piperazine: l-[(δ,6-Dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4-(2-methoxyph enyDpiperazine was reacted by the same way with the example 132 to obtain the titled compound. yield : 94% m.p. : 131-132°C Η NMR(CDCb) δ : 2.16(3H,s), 2.38(3H,s). 2.80(4H,t), 3.0δ(3H.s), 3.35(4H,t), 3.82(3H,s), 3.97(3H,s), 6.83(4H,m ) , 7.08(lH,s) Example 137 l-[N-Ethyl-N-(5,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4- (2-methoxyphenyDpiperazine-' l-[(δ,6-Dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4-(2-methoxyph enyDpiperazine was reacted by the same way with the example 133 to obtain the titled compound. yield : 87% m.p. : 112-113°C Η NMR(CDCb) <5 : 1.08(3H,t), 2.16(3H,s), 2.38(3H,s), 2.77(4H,t), 3.31 (4H,t), 3.δ8(2H,q), 3.81 (3H,s), 3.96(3H,s), 6.88(4H,m), 7.06(lH,s) Example 138 l-[N-Benzyl-N-(5,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4- (2-methoxyphenyl)piperazine: l-[(5,6-Dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4-(2- δ methoxyphenyDpiperazinedOOmg, 0.27mmol) was dissolved in dimethylformamide (15mD and thereto sodium hydride(6.5mg, 0.27mmol) was added, followed by stirring at room temperature for lhr, and successively benzyl bromide(46.2mg, 0.27mmol) was added. The resulting mixture was stirred at room temperature for 16 hrs, 0 concentrated under the reduced pressure and purified by column chromatography (ethylacetate : hexane = l: 2) to obtain the titled compound. yield : 93% m.p. : oil phase 5 Η NMR(CDCb) δ : 2.08(3H,s), 2.35(3H,s), 2.85(4H,t), 3.32(4H,t), 3.81 (3H,s), 3.96(3H,s), 4.76(2H,s), 6.96(4H,m), 7.41 (5H,m) Example 139 l-[N-Cyclopropylmethyl-N-(δ,6-dimethyl-2-methoxypyridin-3-yl) 0 aminocarbonyl]-4-(2-methoxyphenyl)piperazine: l-[(δ,6-Dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4-(2- methoxyphenyDpiperazinedOOmg, 0.26mmol) was dissolved in dimethylformamide(15mI) and thereto sodium hydride(6.2mg, 0.26mmol) was added, followed by stirring at room temperature for 15 min, and 5 successively bromomethylcyclopropane(21.8mg, 0.26mmol) was added. The resulting mixture was stirred at room temperature for 16 hrs, concentrated under the reduced pressure and purified by column chromatography (ethylacetate : hexane = 1: 2) to obtain the titled compound. 30 yield : 78% m.p. : oil phase . Η NMR(CDCb) δ : 0.34(2H,m), 0.49(2H,m), 1.35(lH,m), 2.85(4H,t), 3.28(4H,t), 3.40(2H,s), 3.89(3H,s), 3.97(3H,s), 6.97(4H,m), 7.11(lH,s) 35 Example 140 l-[N-(5,6-Dimethyl-2-methoxypyridin-3-yl)-N-methylaminocarbonyl]-4- (δ-methoxy-2-methylphenyl)piperazine: l-[(5,6-Dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4-(5-methoxy- 2-methylphenyl)piperazine was reacted by the same way with the example 132 to obtain the titled compound. δ yield : 74% m.p. : 91-93°C 1H NMR(CDCb) : 2.15(3H,s), 2.18(3H,s), 2.39(3H,s), 2.67(4H,t), 3.05(3H,s), 3.30(4H,t), 3.75(3H,s), 3.97(3H,s), 6.48(3H,m), 7.10(lH,s) 0 Example 141 l-[N-Ethyl-N-(5,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4- (δ-methoxy-2-methylphenyl)piperazine: l-[(δ,6-Dimethyl-2-methoxypyridin-3-yl)aminocarbony]]-4-(5-methoxy- 2-methylphenyl)piperazine was reacted by the same way with the 5 example 133 to obtain the titled compound. yield : 94% m.p. : oil phase Η NMR(CDCb) δ : 1.09(3H,t), 2.15(3H,s), 2.18(3H,s), 2.39(3H,s), 2.60(4H,t), 3.27(4H,t), 3.δ9(2H,q), 3.7δ(3H,s), 3.96(3H,s), 6.4δ(3H.m), 0 7.08(lH,s) Example 142 l-[N-Benzyl-N-(δ,6-dimethyI-2-methoxypyridin-3-yl)aminocarbonyl]-4- (δ-methoxy-2-methylphenyl)piperazine: δ l-[(δ,6-Dimethyl-2-methoxypyridin-3-yl)aminocarbonyI]-4-(5-methoxy- 2-methylρhenyl)piperazine was reacted by the same way with the example 138 to obtain the titled compound. yield : 97% m.p. : oil phase 30 * H NMR(CDCb) δ : 1.25(3H,t), 2.08(3H,s), 2.14(3H,s), 2.35(3H,s), 2.60(4H,t), 3.32(4H,t), 3.74(3H,s), 3.95(3H,s ) , 4.66(2H,s), 6.44(4H.m), 6.96(5H,m), 7.12(lH,s) Example 143 3δ l-[N-(5-Ethyl-2-methoxy-6-methylpyridin-3-yl ) -N-methylamino cai-bonyl] -4- (3,δ-dimethoxyphenyl)piperazine: l-[(5-E yl-2-me oxy-6-me ylpyridin-3-yl)aminocarbonyl]-4- (3,δ-dimethoxyphenyDpiperazine was reacted by the same way with the example 132 to obtain the titled compound, yield : 87% δ m.p. : 78-79°C J H NMR(CDCb : 1.14(3H,t), 2.41 (3H,s), 2.52(2H,q), 2.91 (4H,t), 3.02(3H,s), 3.28(4H,t), 3.74(6H,s), 3.98(3H,s), 5.98(3H,m), 7.11(lH,s) Mass(EI) m/z : Calcd for C23H32N4O4 428.2423, found 428.2434 10 Example 144 l-[N-(5-Ethyl-2-methoxy-6-methylpyridin-3-yl)-N-methylamino carbonyl3-4-(3,δ-dimethyiphenyl)piperazine: l-[(δ-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4- (3,δ-dimethylphenyl)piperazine was reacted by the same way with the lδ example 132 to obtain the titled compound. yield : 84% m.p. : 86-87°C Η NMR(CDCb) <5 : 1.14(3H,t), 2.23(6H,s), 2.4δ(3H,s), 2.58(2H.q), 2.87(4H,t), 3.05(3H,s), 3.30(4H,t), 3.98(3H,s), 6.46(3H,m). 7.11(lH.s) 20 Mass(EI) m/z : Calcd for C23H32N4O2 396.252δ, found 396.2575 Example 145 l-[N-Ethyl-N-(5-ethyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl] -4 - (3,δ-dimethylpheny Dpiperazine: 2δ l-[(δ-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4- (3,δ-dimethylphenyl)piperazine was reacted by the same way with the example 133 to obtain the titled compound. yield : 86% m.p. : 84-85°C 30 Η NMR(CDCb) <5 : 1.13(6H,m), 2.23(6H,s), 2.41(3H,s), 2.58(2H,q), 2.85(4H,t), 3.26(4H,t), 3.46(2H,q), 3.96(3H,s), 6.45(3H,m), 7.08(lH.s) Example 146 l-[N-(2-Methoxy-6-methyl-5-propylpyridin-3-yl)-N-methylaminυ 3δ carbonyl] -4-(3,δ-dimethoxyphenyl)piperazine: l-[(2-Methoxy-6-methyl-δ-propylpyridin-3-yl)aminocarbυnyl]-4- (3,δ-dimethylphenyl)piperazine was reacted by the same way with the example 132 to obtain the titled compound, yield : 89% m.p. : oil phase δ 1H NMR(CDCb : 1.01 (3H.0, 1.78(2H,m), 2.21 (3H,s), 2.78(2H.t). 3.78(6H,s), 3.86(4H,t), 3.99(3H,s), 4.00(3H,s), 4.22(4H,t), 6.01 (3H,m), 7.02QH.S) Example 147 10 l-[N-(6-Ethyl-2-methoxy-δ-methylpyridin-3-yl)-N-methylamino carbonyl] -4- (3,δ-dimethoxyphenyl)piperazine: l -[(6-Ethyl-2-methoxy-5-methylpyridin-3-yl)aminocarbonyl]-4- (3,δ-dimethoxyphenyl)piperazine was reacted by the same way with the example 132 to obtain the titled compound, lδ yield : 85% m.p. : oil phase Η NMR(CDCbH : 2.21 (3H,t), 2.21 (3H,s), 2.4δ(2H,q), 3.21 (4H,t), 3.40(3H,s), 3.67(4H,t), 3.77(6H,s), 4.01 (3H,s), 6.07(3H,m ) , 6.96(lH.s), 8.07(lH,s) 20 Example 148 l-[N-(2-Methoxy-5-methyl-6-propylpyridin-3-yl ) -N-methylamino carbonyl] -4- (3,δ-dimethoxyphenyl)piperazine: l-[(2-Methoxy-δ-methyl-6-propylpyridin-3-yl)aminocarbυnyl]-4- 25 (3,5- dimethoxyphenyDpiperazine was reacted by the same way with the example 132 to obtain the titled compound. yield : 86% m.p. : 106-107 * 0 Η NMR(CDCb) δ : 0.98(3H,t), 1.73(2H,q), 2.18(3H,s). 2.63(2H.t ) . 30 2.92(4H,t). 3.05(3H,s), 3.29(4H,t), 3.74(6H,s), 3.96(3H,s ) . 6.00(3H.m), 7.11(lH,s) Mass(EI) m/z : Calcd for C24H34N4O4 442.2580, found 442.2543 Example 149 35 l-[N-(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)-N-methylamino carbonyl]-4-(3,δ-dimethoxyphenyl)piperazine: l-[(δ-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4- (3,δ-dimethylphenyl)piperazine was reacted by the same way with the example 132 to obtain the titled compound, yield : 89% δ m.p. : oil phase l H NMR(CDCb) δ : 2.δ0(3H,s), 2.70(3H,s), 2.97(4H,t), 3.09(3H,s), 3.33(4H,t), 3.7δ(6H,s), 4.06(3H,s), 6.03(3H,m), 7.72(lH,s) Mass(EI) m/z : Calcd for C23H30N4O5 442.2216, 442.2229 0 Example 150 l-[N-Ethyl-N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl ]-4-(3,δ-dimethoxyphenyl)piperazine: l-[(δ-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4- ( 3, δ- dimethoxyphenyDpiperazine was reacted by the same way with the 5 example 133 to obtain the titled compound. yield : 87% m.p. : oil phase * H NMR(CDCb) δ : 1.09(3H,t), 2.49(3H,s), 2.70(3H.s), 3.00(4H,t), 3.32(4HΛ), 3.77(6H,s), 4.01 (3H,s), 4.09(2H,q), δ.98(3H,m). 7.76(lH.s) 0 Example 151 l -[N-(5-Acetyl-2-methoxy-6-methylpyridin-3-yl ) -N-methylamino carbonyl] -4- (3,δ-dimethylphenyl)piperazine: l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4- 25 (3,5-dimethylphenyl)piperazine was reacted by the same with the example 132 to obtain the titled compound. yield : 88% m.p. : oil phase Η NMR(CDCb) 5 : 2.24(6H,s), 2.50(3H,s), 2.70(3H,s). 2.93(4H,t), 30 3.09(3H,s), 3.28(4H,t), 4.06(3H,s), 6.46(3H,m), 7.73(lH,s) Example 152 l-{N-[5-(l-Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]-N-methyl aminocarbony 1) -4- (3,5-dimethoxyphenyl)piperazine: 35 l-[N-(δ-Acetyl-2-methoxy-6-methylpyridin-3-yl)-N-methylamino carbonyl] -4- (3,δ-dimethoxyphenyl)piperazine(0.47mmol ) was dissolved in anhydrous ethanol(15ml) and thereto sodium borohydride(17.3mg) was added, then followed by stirring at room temperature for 2 hrs. The resulting mixture was concentrated under the reduced pressure to remove ethanol and purified by column chromatography(ethylacetate : hexane = 21) to obtain the titled compound, yield : 97% m.p. : oil phase Η NMR(CDCb) $ : 1.14(3H,d), 2.44(3H,s), 2.93(4H,t), 3.06(3H,s), 3.30(4H,t), 3.74(6H,s), 3.98(3H,s), 5.03(lH,q), 6.02(3H,m), 7.δO(lH,s) Example lδ3 l-<N-Ethyl-N-[δ-d-hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl] aminocarbonyl}-4-(3,δ-dimethoxyphenyl)piperazine; l-[N-Ethyl-N-(δ-cetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl] -4-(3,5-dimethoxyphenyl)piperazine was reacted by the same way with the example lδ2 to obtain the titled compound. yield : 96% m.p. : oil phase 1H NMR(CDCb : 1.09(3H,t), 1.41 (3H,d), 2.44(3H,s), 2.91 (4H.t), 3.27(4H,t), 3.54(lH,q), 3.74(6H,s), 3.96(3H,s), 5.03(lH,q ) , 6.02(3H.m), 8.46(lH,s) Example 154 l -{N-[δ-(l-HydroxyethyD-2-methoxy-6-methylpyridin-3-yl]-N- methylaminocarbonyl]-4- (3,5-dimethylphenyl)piperazine: l-[N-Methyl-N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)amino carbonyl]-4-(3,δ-dimethylphenyl)piperazine was reacted by the same way with the example 152 to obtain the titled compound, yield : 97% m.p. : oil phase Η NMR(CDCb) <5 : 1.41 (3H,d), 2.24(6H,s), 2.44(3H,s), 2.91 (4H,t), 3.06(3H,s), 3.26(4H,t), 3.99(3H,s), 5.03(lH,q), 6.49(3H,m), 7.δ0(lH,s) Example lδ5 l- { N-[δ-d-Hydroxy-l-methylethyl)-2-methoxy-6-methylpyridin-3-yl]- N-methylaminocarbonyl}-4-(3,δ-dimethoxyphenyl)piperazine: l-[N-Methyl-N-(δ-acetyl-2-methoxy-6-methylpyridin-3-yDamino carbonyl]-4-(3,δ-dimethoxyphenyl)piperazine(221mg, O.δmmol) was dissolved in tetrahydrofuran (10ml) and thereto methyl magnesium bromide(0.50ml, l.δOmmol). The resulting mixture was refluxed for lδ δ hrs, concentrated under the reduced pressure to remove used solvent, extracted with ethylacetate, filtered to dryness, and purified by column chromatography(ethylacetate : hexane =1:2) to obtain the titled compound, yield : 92% 0 m.p. : oil phase Η NMR(CDCb) δ : l.δ9(6H,s), 2.66(3H,s), 2.93(4H,t), 3.06(3H,s), 3.30(4H,t), 3.74(6H,s), 3.99(3H,s), 6.03(3H,m), 7.45(lH,s) Example 156 5 l-{N-[5-(l-Hydroxy-l-methylpropyl)-2-methoxy-6-methylpyridin-3-yl] -N-methylaminocarbonyl) -4- (3,5-ctimethylphenyDpiperazine: l-[N-Methyl-N-(δ-acetyl-2-methoxy-6-methylpyridin-3-yl)aminυ carbonyl]-4-(3,δ-dimethylphenyl)piperazine(213mg, O.δmmol) was dissolved in tetrahydrofuran (10ml) and thereto methyl magnesium 0 bromide (O.δOml, l.δOmmol) was added slowly, then refluxed for 15 hrs. The resulting mixture was concentrated under the reduced pressure to remove the used solvent, extracted with ethylacetate. filtered to dryness. and purified by column chromatography(ethylacetate : hexane =1:2) to obtain the titled compound. 25 yield : 88% m.p. : oil phase Η NMR(CDCb) S : 0.79(3H,t), 1.58(3H,s), 1.8δ(2H,q), 2.61 (3H,s), 2.99(4H,t), 3.07(3H,s), 3.30(4H,t), 3.76(6H,s), 6.12(3H,m), 7.47(lH,s) 30 Example 157 l- { N-[2-Methoxy.-5-(l-methoxyethyl)-6-methylpyridin-3-yl]-N-methyl aminocarbony 1 } -4- (3,δ-dimethoxyphenyl)piperazine: l-{N-[δ-(l-Hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]amino carbυnyl}-4-(3,δ-dimethoxyphenyl)piperazine was reacted by the same 35 way with the example 132 to obtain the titled compound, yield : 95% m.p. : 117-119 * 0 Η NMR(CDCb) δ : 1.34(3H,t), 2.43(3H,s), 2.94(4H,t), 3.06(3H,s), 3.18(3H,s), 3.30(4H,t), 3.74(6H,s), 3.99(3H,s), 4.44(lH,q), 6.02(3H,m), 7.37(lH,s) δ Example 158 1 -[N- (2-Methoxy-6-methyl-5- vinylpyridin-3-yl)-N-methylamino carbonyl]-4-(3,δ-dimethoxyphenyl)piperazine: l-[(2-Methoxy-6-methyl-δ-vinylpyridin-3-yl)aminocarbonyl]-4- 0 (3,δ-dimethoxyphenyl)piperazine was reacted by the same way with the example 132 to obtain the titled compound. yield : 94% m.p. : oil phase l H NMR(CDCb) δ : 2.46(3H,s), 2.93(4H,t), 3.07(3H,s), 3.30(4H,t), lδ 3.73(6H,s), 3.99(3H,s), δ.2δ(lH,d), 5.48(lH,d), 6.01 (3H,m), 6.78(lH,s), 7.43(lH,s) Example 159 l-[N-(2-Methoxy-6-methyl-5-vinylpyridin-3-yl)-N-methylamino 20 carbonyl] -4- (3,δ-dimethylphenyl)piperazine: l-[(2-Methoxy-6-methyl-δ-vinylpyridin-3-yl)aminocarbonyl]-4- (3,δ-dimethylphenyl)piperazine was reacted by the same way with the example 132 to obtain the titled compound. yield : 89% 25 m.p. : oil phase 1H NMR(CDCb) δ : 2.24(6H,s), 2.43(3H,s), 2.90(4H,t), 3.04(3H,s), 3.27(4H,t), 3.99(3H,s), δ.23(lH,d), δ.4δ(lH,d), 6.0δ(3H,m), 6.77(lH,s), 7.40(lH,s) 30 Example 160 1 -[N-Ethyl-N- (2rmethoxy-6-methyl-δ-vinylpyridin-3-yl)aminocarbonyl] -4 - (3,δ-dimethoxyphenyl)piperazine: 1 -[ (2-Methoxy-6-methyl-δ- vinylpyridin-3-yl)aminocarbonyl] -4- (3.5-dimethoxyphenyl)piperazine was reacted by the same way with the 35 example 133 to obtain the titled compound. vield : 92% m.p. : oil phase Η NMR(CDCb) δ : 1.09(3H,t), 2.43(3H,s), 2.94(4H,t), 3.28(4H,t), 3.77(6H,s), 4.01(3H,s), 4.11(2H,q), δ.2δ(lH,d), δ.49(lH,d), δ.98(3H,m), 6.77(lH,s), 7.44(lH,s) δ Example 161 l-[N-(δ-Isopropenyl-2-methoxy-6-methylpyridin-3-yl)-N-methylamino carbonyl] -4- (3,5-dimethoxyphenyDpiperazine: l-[(5-Isopropenyl-2-methoxy-6-methylpyridin-3-yDaminocarbonyl]-4- 0 (3.5-dimethoxyphenyl)piperazine was reacted by the same way with the example 132 to obtain the titled compound. yield : 92% m.p. : oil phase Η NMR(CDCb) : 1.98(3H,s), 2.43(3H,s), 2.92(4H,t), 3.06(3H.s), lδ 3.29(4H,t), 3.74(6H,s), 3.99(3H,s), 4.84(lH,s), δ.30(lH,s). 6.01 (3H.m), 7.10(lH,s) Example 162 l-[N-(δ-Isopropenyl-2-methoxy-6-methylpyridin-3-yl)-N-methylamino 20 carbonyl] -4- (3,δ-dimethylphenyl)piperazine: l-[(δ-Isoprυphenyl-2-methoxy-6-methylpyridin-3-yl)aminocarbυnyl]-4- (3,δ-dimethylphenyl)piperazine was reacted by the same way with the example 132 to obtain the titled compound. yield : 91% 2δ m.p. : oil phase 1H NMR(CDCb) 5 : 1.98(3H,s), 2.24(6H,s), 2.43(3H,s), 2.90(4H,t), 3.06(3H.s), 3.28(4H,t), 4.00(3H,s), 4.84(lH,s), 5.19(lH,s), 6.46(3H,m), 7.10(lH,s) 30 Example 163 Ethyl 2-({[4-(3,5 dimethoxyphenyl)piperazino]carbonyl)(5-acetyl-2- methoxy-6-methylpyridin-3-yDamino)acetate: l-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4- (3,δ-dimethoxyphenyl)piperazine(200mg, 0.δmmol) was dissolved in 35 dimethylformamidedδml) and thereto sodium hydride(18.δmg, O.δmmol) was added, then followed by stirring at room temperature for lδ min, and ethylbromoacetate(83.5mg, 0.5mmol) was added. The resulting mixture was stirred at room temperature for 3 hrs, concentrated under the reduced pressure to remove the used solvent, and purified by column chromatography (ethylacetate : hexane =1:2) to obtain the titled 5 comιxund. yield : 84% m.p. : oil phase 'II NMR(CDCb : 1.26(3H,t), 2.δl(3H,s), 2.69(3H,s), 3.04(4H,t), 3.43(4H,t), 3.7δ(6H,s), 4.05(3H,s), 4.15(2H,q), 4.19(2H,s), 6.08(3H,s), 10 7.96(lH,s) Example 164 Ethyl 2-({[4-(3,δ-dimethylphenyl)piperazino]carbonyl)(δ-acetyl-2- methoxy-6-methylpyridin-3-yl)amino)acetate: lδ 1 -[(δ-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4- (3,5-dimethylphenyDpiperazine was reacted by the same way with the example 163 to obtain the titled compound. yield : 80% m.p. : oil phase 20 'IT NMR(CDCb) 5 : 1.25(3H,t), 2.δ6(3H,s), 2.69(3H,s ) , 3.00(4H,t), 3.29(4H,t), 3.78(6H,s), 4.06(3H,s), 4.18(2H,s), δ.99(3H.m ) , 7.98(lH.s) Example 16δ 2-({[4-(3,5-Dimethoxyphenyl)piperazino]carbonyl}(5-acetyl-2-methoxy-6- 25 methylpyridin-3-yl)amino)acetic acid: Ethyl ({[4-(3,5-dimethoxyphenyl)piperazino]carbonyD(δ-acetyl-2-methoxy -6-methylpyridin-3-yl)amino)acetate(200mg, 0.38mmol) was dissolved in mixed solvent of dioxane : distilled water =4:l(lδml), and lithium hydroxide hydrate (48. lmg, 1.14mmol) was added, then followed by 30 stirring at room temperature for 3 hrs. The resulting mixture was made acidic with IN-HCl, extracted with ethylacetate, filtered to dryness, concentrated under the reduced pressure and purified by column chromatography(ethylacetate : hexane = 1 : 2) to obtain the titled compound. 3δ yiel : 94% m.p. : 13δ-137 * 0 ■ H NMR(CDCb) : 2.52(3H,s), 2.69(3H,s), 3.11(4H,t), 3.49(4H,t), 3.74(6H,s), 4.05(3H,s), 4.24(2H,s), 6.15(3H,m), 7.83(lH,s) Example 166 δ Ethyl 2-({[4-(3,δ-dimethoxyphenyDpiperazino]carbonyl}[δ- (l-hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]amino)acetate: Ethyl 2-({[4-(3,δ-dimethoxyphenyl)piρerazino]carbonyl)(δ-acetyl-2- methoxy-6-methylpyridin-3-yl)amino)acetate was reacted by the same way with the example 152 to obtain the titled compound. 0 yield : 97% m.p. : 125-127 * 0 'II NMR(CDCb) 5 : 1.26(3H,t), 1.42(3H,d), 2.44(3H,s), 3.04(4H,t), 3.31 (4H,t), 3.75(6H,s), 3.97(3H,s), 4.16(2H,q), 4.19(2H,s), 6.15(3H,m), 7.69(lH,s) 5 Example 167 Ethyl 2-({[4-(3,5-dimethoxyphenyl)piperazino]carbonyl)[δ- (l-hydiOxyethyl)-2-methoxy-6-methylpyridin-3-yl]amino)acetate: Ethyl 2-({[4-(3,δ-dimethoxyphenyl)piperazino]carbonyl}[δ- 0 ( 1 -hydiOxyethyl)-2-methoxy-6-methylpyridin-3-yl]aminυ)acetate was reacted by the same way with the example 164 to obtain the titled compound, yield : 92% m.p. : oil phase 25 'II NMR(CDCb) 5 : 1.41(3H,d), 2.44(3H,s), 2.98(4H,t), 3.36(4H,t), 3.74(6H,s), 3.98(3H,s), 4.40(2H,s), 5.00(lH,q), 6.08(3H,m), 7.69(lH,s) Example 168 Ethyl 2- ({[4-(3,δ-dimethylphenyl)piperazino]carbonyl}[δ- 30 (1 -hydiOxyethyl)-2-methoxy-6-methylpyridin-3-y l]amino)acetate: Ethyl 2-({[4-(3,δ-^dimethylphenyl)piperazino]carbonyl) (δ-acetyl-2- methoxy-6-methylpyridin-3-yl)amino)acetate was reacted by the same way with the example lδ2 to obtain the titled compound. yield : 94% 35 m.p. : 68-70 * 0 Η NMR(CDCb) δ : 1.13(3H,t), 1.47(3H,d), 2.33(6H,s). 2.44(3H,s), 2.9δ(4H,t), 3.30(4H,t), 3.98(3H,s), 4.10(2H,q), 5.01(lH,q), 6.46(3H,m), 7.71(lH,s) Example 169 δ 2-({[4-(3,δ-Dimethylphenyl)piperazino]carbonyl}[δ-(l-hydroxyethyl)-2- methoxy-6-methylpyridin-3-yl]amino)acetic acid: Ethyl 2-({[4-(3,5-dimethylρhenyl)piperazino]carbonyl}[5- (1 -hydroxyethyl)-2-meΛoxy-6-met^ylpyridin-3-yl]amino)acetate was reacted by the same way with the example 165 to obtain the titled 10 compound, yield : 92% m.p. : 114-116 * C 1H NMR(CDCb) 5 : 1.40(3H,d), 2.23(6H,s), 2.40(3H,s), 2.91 (4H,t), 3.21(4H,t), 3.98(3H,s), 4.06(2H,s), 4.90(lH,q), 6.50(3H,m), 6.δl(lH,s) lδ Example 170 l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-phenylpiperazine a) 3,4-Dimethyl anisole: To 3,4-dimethylphenol(19.3g, 0.16mol), methanol(lδθml) and KOH(9.6δg, 20 0.2δmol) were added and then refluxed for 2hrs. Methyl iodide(36.δg, 0.25mol) was added thereto, refluxed for 3 hours and then followed by addition of waterdδOml). The resulting mixture was extracted with ethylacetate and purified by column chromatography to obtain the titled compound. 2δ yield : 81% 1H NMR(δ00MHz, CDCb): δ 2.20(3H,s), 2.24(3H,s), 3.77(3H,s), 6.71 (2H,m), 6.97(lH,s) b) 4,δ-Dimethyl-2-nitroanisole: Trifluoroacetic acid(2δ0ml) was added into 3,4-dimethylanisole(17.1g, 30 0.13mol), successively sodium nitrite(16.6g, 0.24mol) was added slowly in water bath, and stirred at room temperature for 14 hrs. After trifluoroacetic acid was removed and water was added thereto, the resulting mixture was extracted with ether, and purified by column chromatography to obtain the titled compound. 35 yield : 55% 1H NMR(500MHz, CDCb): δ 2.25(3H,s), 2.32(3H.s), 3.94(3H,s), 6.85(lH,s), 7.70(lH,s) c) 4,5-Dimethyl-2-methoxyaniline: Tetrahydrofuran (100ml) and ethanol(40ml) were added into 4,5-dimethyl-2-nitroanisole(7.80g, 0.043mol) and then added 10% Pd/activated carbon(0.57g) slowly, hydrogenated for 5 hrs. The reaction was completed by the same way with the above and the resulting product was purified by column chromatography to obtain the titled compound. yield : 82% * H NMR(500MHz, CDCb): δ 2.23(3H,s), 2.27(3H,s), 3.90(3H,s), 6.80dH,s), 7.68(lH,s) d) Phenyl N-(4,5-dimethyl-2-methoxyphenyl)carbamate: To 4,δ-dimethyl-2-methoxyaniline(4.50g, 0.03mol), methylene chloridedOOml) was added and phenyl chloroformate(4.80g, 0.03mol) was added slowly. The resulting solution was stirred for 2 hrs and thereto water(150ml) was added, and extracted with methylene chloride and purified by column chromatography to obtain the titled compound, yield : 98% *H NMR(δOOMHz, CDCb): δ 2.24(3H,s), 2.27(3H,s), 3.89(3H,s). 6.85(lH,s), 7.20(5H,m), 7.90(lH,s) e ) l-[(4,5-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-phenylpiperazine: Phenyl N-(4,5-dimethyl-2-methoxyphenyl)carbamate(δ.422g, 0.02mυl) and 1 -phenylpiperazine(3.44g, 0.02mol) were dissolved in tetrahydrofuran(lθml). After DBU(3.04g, 0.02mol) was added, the δ resulting solution was stirred at room temperature for 2 hrs, concentrated and purified by column chromatography to obtain the titled compound. yield : 85% m.p.: 143-144 * 0 0 Η NMR(500MHz, CDCb): δ 2.20(3H,s), 2.21(3H,s), 3.25(4H,t), 3.67(4H,t), 3.85(3H,s), 6.64(lH,s), 6.94(3H,m), 6.99(lH,s), 7.29(lH,t), 7.91(lH,s) Example 171 l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4- 5 (3,5-dimethoxyphenyDpiperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)carbamate and l-(3,δ-dimethoxyphenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound, yield -' 85% m.p. : 119-120O Η NMR(500MHz, CDCb): δ 2.20(3H,s), 2.21 (3H,s), 3.27(4H,t), 3.70(4H,t), 3.79(6H,s), 3.85(3H,s), 6.17(2H,m), 6.65(lH,s), 6.98dH,s), 7.90dH,s) Mass(EI) m z : Calcd for C22H29N3O4 399.21δ8, found 399.2168 Example 172 1 -[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4- (3,δ-dimethylphenyl)piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)carbamate and l-(3,δ-dimethylphenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound. yield : 88% m.p. : 177-178 * 0 1H NMR(500MHz, CDCb): δ 2.20(3H,s), 2.21 (3H,s), 2.29(6H,s), 3.23(4H,0, 3.66(4H,t), 3.8δ(3H,s), 6.δ8(2H,m), 6.6δ(lH,s), 6.99(lH,s), 7.92(lH,s) Mass(EI) m/z : Calcd for C22H29N3O2 367.22δ9, found 367.2290 Example 173 l-[4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(2,3-dimelhylijhenyl) piperazine: Phenyl N-(4,5-dimethyl-2-methoxyphenyl)carbamate and l-(2,3-dimethylphenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound. yield : 95% m.p. : 140-142 * 0 * H NMR(500MHz, CDCb): δ 2.21(3H,s), 2.22(3H,s), 2.27(3H.s). 2.29(3H,s), 2.95(4H,t), 3.67(4H,t), 3.85(3H,s), 6.65(lH,s), 7.01(3H,m), 7.93(lH,s) Example 174 l-[(4,5-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4- (2,3,δ,6-tetramethylphenyl)piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)carbamate and l-(2,3,δ,6-tetramethylphenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound, yield -' 93% δ m.p. : oil phase Η NMR(500MHz, CDCb): δ 2.20(9H,s), 2.21 (9H,s), 3.17(4H,t), 3.63(4H,t), 3.84(3H,s), 6.64(lH,s), 6.84dH,s), 7.9δdH,s) Example 17δ 10 l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3,δ-difluorophenyl) piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)carbamate and l-(3,δ-difluorophenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound, lδ yield : 89% m.p. : 102-103 * 0 ] H NMR(500MHz, CDCb): δ 2.20(3H,s), 2.22(3H,s), 3.29(4H.t), 3.68(4H,t). 3.8δ(3H,s), 6.6δ(lH,s), 6.97(3H,m), 7.89(lH,s) 20 Example 176 l-[ ( 4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(2-chlorophenyl) piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)carbamate and l-(2-chlorophenyl)piperazine were reacted by the same way with the 25 example 170 to obtain the titled compound. yield : 90% m.p. : 176-177 * 0 ■ H NMR(500MHz, CDCb): * 2.21(3H,s), 2.22(3H,s), 3.10(4H,t,J=δ.0Hz), 3.69(4H,t,J=5.0Hz), 3.85(3H,s), 6.6δ(lH,s), 7.02(2H,m), 7.24dH,m), 30 7.39(lH.dJ=4.0Hz), 7.92dH,s) Example 177 l-[(4,5-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3-chlorophenyl) piperazine: 35 Phenyl N-(4,5-dimethyl-2-methoxyphenyl)carbamate and l -(3-chlorophenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound, yield : 84% m.p. : 7δ-76 * C Η NMR(600MHz, CDCb): δ 2.20(3H,s), 2.22(3H,s), 3.27(4H,tJ=δ.0Hz), 3.68(4H,t,J=5.0Hz), 3.8δ(3H,s), 6.65dH,s), 6.90(3H,m), 7.21dH,t), 7.90(lH,s) Mass(EI) m/z : Calcd for C20H24N3O2CU 373.15δ7, found 373.1δ90 Example 178 l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(2-hydroxyphenyl) piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)carbamate and l -(2-hydroxyphenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound. yield : 87% m.p. : 197-199 * 0 Η NMR(δ00MHz, CDCb): δ 2.20(3H,s), 2.21(3H,s), 2.98(4H,t), 3.72(4H,t), 3.84(3H,s), 6.6δ(lH,s), 6.89(lH,t), 7.00(2H,m), 7.13(2H,m), 7.89(lH,s) Example 179 l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3-hydroxyphenyl) piixjrazine- ' Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)carbamate and l-(3-hydroxyphenyl) were reacted by the same way with the example δ 170 to obtain the titled compound. yield : 88% m.p. : 177-178 * 0 Η NMR(δ00MHz, CDCb): δ 2.19(3H,s), 2.21(3H,s), 3.24(4H,t), 3.68(4H,t), 3.85(3H,s), 6.41(3H,m), 6.6δ(lH,s), 6.98(lH,s), 7.13(lH,t), 7.88(lH,s) 0 Example 180 l -[(4.5-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3-thiophenyl) piperazine: Phenyl N-(4,5-dimethyl-2-methoxyphenyl)carbamate and δ l-(3-thiophenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound. - 6 - yield: 79% m.p.: 108-110 * 0 Η NMR(500MHz, CDCb): δ 2.20(3H,s), 2.21(3H,s), 3.26(4H,t), 3.65(4H,t), 3.84(3H,s), 6.64(lH,s), 6.97(4H,m), 7.05dH,s), 7.89(lH,s) Example 181 l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(2-acetoxyphenyl) piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)carbamate and l-(2-acetoxyphenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound. yield: 84% m.p.: 129-131 * 0 Η NMR(500MHz, CDCb): δ 2.20(3H,s), 2.21 (3H,s), 2.32(3H,s), 3.05(4H,t), 3.63(4H,t), 3.85(3H,s), 6.64(lH,s), 6.99(lH,s), 7.04(lH,m), 7.17(2H,m), 7.22(lH,m), 7.90(lH,s) Example 182 l-[(4,5-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3-acetoxyphenyl) piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)carbamate and l-(3-acetoxyphenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound. yield: 87% m.p.: 154-156 * C ■ H NMR(δO0MHz, CDCb): δ 2.20(3H,s), 2.21 (3H,s), 2.29(3H,s), 3.27(4H,t), 3.68(4H,t), 3.8δ(3H,s), 6.64dH,s), 6.66(2H,m), 6.82(lH,m), 6.98(lH,s), 7.90(lH,s) Example 183 l-[(4,5-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(2-methoxyphenyl) piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)carbamate and l-(2-methoxyphenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound. yield: 90% m.p.: 144-145 * C 1H NMR(500MHz, CDCb): δ 2.20(3H,s), 2.22(3H,s), 2.26(3H,s), 2.95(4H,t, J=δ.0Hz), 3.6δ(4H,tJ=5.0Hz), 3.78(3H,s), 3.85(3H,s), 6.59(lH,s), 6.6δ(lH,s), 7.00(lH,s), 7.11(lH,s), 7.93(lH,s) 5 Example 184 l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(δ-methoxy-2- methylphenyDpiperazine: Phenyl N-(4,5-dimethyl-2-methoxyphenyDcarbamate and 10 l-(5-methoxy-2-methylphenyDpiperazine were reacted by the same way with the example 170 to obtain the titled compound. yield: 88% m.p.: 140-141 * 0 1H NMR(500MHz, CDCb): δ 2.20(3H,s), 2.22(3H,s), 2.26(3H,s), 2.95(4H,t. lδ J=δ.0Hz), 3.6δ(4H,tJ=δ.0Hz), 3.78(3H,s), 3.8δ(3H,s), 6.59(lH,s), 6.6δ(lH,s). 7.00(lH,s), 7.11 (lH.s), 7.93(lH,s) Example 18δ l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(2-methoxy-δ- 20 methylphenyDpiperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)carbamate and l-(2-methoxy-δ-methylphenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound. yield: 80% 2δ m.p.: 107-108 * 0 1H NMR(500MHz, CDCb): δ 2.20(3H,s), 2.21(3H,s), 2.29(3H,s), 3.10(4H,t, J=δ.0Hz), 3.69(4H,tJ=5.0Hz), 3.8δ(3H,s), 3.86(3H,s), 6.55(lH,s), 6.79(2H,m). 7.01 (lH,s), 9.94(lH,s) 30 Example 186 l-[(4,5-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(2-methoxy-δ- phenylphenyDpiperazine: Phenyl N-(4,5-dimethyl-2-methoxyphenyl)carbamate and l-(2-methoxy-δ-phenylphenyl)piperazine were reacted by the same way 3δ with the example 170 to obtain the titled compound. yield: 91% m.p.: 139-140 * 0 1H NMR(500MHz, CDCb): δ 2.21 (3H,s), 2.22(3H,s), 3.20(4H,t), 3.74(4H,t), 3.85(3H,s), 3.94(3H,s), 6.6δdH,s), 7.02(2H,m), 7.32(2H,m), 7.42(2H,t), 7.δδ(2H,d), 7.93dH,s) δ Example 187 l-[(4,5-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(2-isopropenyl phenyDpiperazine: Phenyl N-(4,5-dimethyl-2-methoxyphenyl)carbamate and 0 l-(2-isopropenylphenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound. yield: 80% m.p.: 134-135 * 0 1H NMR(500MHz, CDCb): δ 2.20(3H,s), 2.21(6H,s), 3.10(4H.t), 3.64(4H.t). 5 3.85(3H,s), δ.08(lH,s), δ.l4(lH,s), 6.64(lH,s), 7.0δ(3H,m), 7.70(lH,m), 7.92(lH,s) Example 188 l-[(4,5-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(l-naphthyl) 20 piperazine: Phenyl N-(4,5-dimethyl-2-methoxyphenyl)carbamate and l -(l-naphthyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound. yield: 92% 2δ m.p.: 160-162 * 0 Η NMR(δOOMHz, CDCb): δ 2.20(3H,s), 2.24(3H,s), 3.31(4H,t,J=5.0Hz). 3.83(3H,s), 4.04(4H,t), 6.39(2H,m), 6.69(lH,s), 7.13(lH,t), 7.30(lH,s), 7.46(lH,s) 30 Example 189 1 -[(4,δ-Dimethyl-.2-methoxyphenyl)aminocarbonyl] -4- ( 1 -anthranyl) piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)carbamate and l-(l-anthranyl)piperazine were reacted by the same way with the 35 example 170 to obtain the titled compound. yield: 94% m.p.: 74-75 * 0 l H NMR(500MHz, CDCb): δ 2.20(3H,s), 2.22(3H,s), 3.24(4H,t), 3.70(4H,t), 3.86(3H,s), .6.70dH,s), 7.0δ(3H,m), 7.45(5H,m), 8.00(2H,m) 5 Example 190 l-[N-(4,5-Dimethyl-2-methoxyphenyl)-N-methylaminocarbonyl]-4- (3,5- dimethoxyphenyDpiperazine: l-[(4,5-dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3,δ-dimethoxy phenyl)piperazine(0.2g, O.δmmole) was dissolved in 10 dimethylfoπnamidedδml), sodium hydride(12mg, O.δmmole) was added thereto slowly, and then the resulting mixture was stirred at room temperature for lδ min, then followed by addition of iodomethane(71mκ, O.δmmole) and subsequently at room temperature for 16 hours. The resulting mixture was concentrated under the reduced pressure to lδ remove the used solvent, extracted with methylene chloride, dried, filtered and purified by column chromatography to obtain the titled compound. yield: 92% m.p.: 86-88 * 0 20 Η NMR(δOOMHz, CDCb): δ 2.21 (3H,s), 2.24(3H,s), 2.92(4H.t), 3.00(3H,s), 3.31(4H,t). 3.75(6H,s), 3.83(3H,s), 6.00(3H,m ) , 6.71(lH.s ) , 6.83(lH,s) Mass(EI) m/z : Calcd for C23H31N3O4 413.2314, found 413.2293 25 Example 191 l-[N-(4,5-Dimethyl-2-methoxyphenyl)-N-methylaminocarbonyl]-4- (3,δ-dimethylphenyl)piperazine: l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3,δ-dimethyl phenyDpiperazine was reacted by the same way with the example 190 30 to obtain the titled compound. yield-' 90% m.p.: 137-138 * 0 1H NMR(δ00MHz, CDCb): δ 2.15(3H,s), 2.24(9H,s), 2.88(4H,t), 3.06(3H,s), 3.29(4H,t), 3.83(3H,s), 6.4δ(3H,m), 6.71 (lH.s), 6.83(lH,s) 35 Mass(EI) m/z : Calcd for C23H29N3O2 381.2416, 381.2436 Example 192 l-[N-(4,δ-Dimethyl-2-methoxyphenyl)-N-methylaminocarbonyl]-4- (3,δ-difluorophenyl)piperazine: l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3,δ-difluorophenyl) δ piperazine was reacted by the same way with the example 190 to obtain the titled compound. yield: 87% m.p.: 98-100 * 0 Η NMR(500MHz, CDCb): δ 2.16(3H,s), 2.2δ(3H,s), 2.92(4H,t), 10 3.0C(3H,s), 3.29(4H,t), 3.83(3H,s), 6.23(3H,m), 6.72(lH,s), 6.83(lH,s) Example 193 1 -[N-Ethyl-N-(4,5-dimethyl-2-methoxyphenyl)aminocarbonyl] -4- (3,5-dimethoxyphenyDpiperazine-' lδ l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3,δ-dimethoxyphen yl)piρerazine(0.2g, O.δmmole) was dissolved in dimethylformamidedδml), and thereto sodium hydride(12mg, O.δmmole) was added slowly. The resulting mixture was stirred at room temperature for lδ min. After iodoethane(78mg, O.δmmol) was added, the resulting mixture was stirred 20 at room temperature for 16 hours. The resulting mixture was concentrated under the reduced pressure to remove the used solvent, extracted with methylene chloride, dryed, filtered and purified by column chromatography to obtain the titled compound, yield: 89% 2δ m.p.: oil phase Η NMR(500MHz, CDCb): δ 1.09(3H,t), 2.16(3H,s), 2.24(3H,s), 2.7δ(4H.t), 3.28(41-1,1), 3.52(2H,q), 3.75(6H,s), 3.81(3H,s), 5.98(3H,m), 6.70(lH.s). 6.80(lH,s) 30 Example 194 l-[N-(4,δ-Dimethyl-2-methoxyphenyl)-N-ethylaminocarbonyl]-4- (3,5-dimethylphenyl)piperazine: l-[(4,5-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3,δ-dimethyl phenyDpiperazine was reacted by the same way with the example 193 35 to obtain the titled compound. vield: 93% m.p.: 80-82 * 0 1H NMR(500MHz, CDCb): δ 1.21(3H,t), 2.15(3H,s), 2.23(9H,s), 2.90(4H,t), 3.2δ(4H,t), 3.59(2H,q), 3.81(3H,s), 6.45(3H,m), 6.69(lH,s), 6.81(lH,s) δ Example 19δ 1 -[N - (4,δ-Dimethyl-2-methoxypheny D-N-ethy laminocarbonyl] -4 - (3,δ-difluorophenyl)piperazine: 1 -[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl] -4- (3,δ-difluoropheny 1) piperazine was reacted by the same way with the example 193 to 0 obtain the titled compound. yield: 87% m.p.: oil phase 1H NMR(δ00MHz, CDCb): δ 1.09(3H,t), 2.16(3H,s). 2.2δ(3H,s). 2.90(4H,t), 3.27(4H,t), 3.δ2(2H,q), 3.81(3H,s), 6.24(3H,m), 6.70(lH,s), 6.81(lH,s) lδ Example 196 l-[N-Isopropyl-N-(4,δ-dimethyl-2-methoxyphenyl)aminocarbonyl]-4- (3,5-difluorophenyDpiperazine: l-[(4,5-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3,δ-difluorophenyl) 20 piperazine (0.2g, 0.δ2mmole) was dissolved in dimethylformamidedδml) and thereto sodium hydride(12.48mg, 0.52mmole) was slowly added. The resulting mixture was stirred at room temperature for 15 min. After 2-iodopropane(87.88mg, 0.52mmole) was added thereto, the resulting mixture was stirred at room temperature for 16 hours. The resulting 25 mixture was concentrated under the reduced pressure to remove the used solvent, extracted with methylene chloride, dryed, filtered and purified by column chromatography to obtain the titled compound. yield: 84% m.p.: oil phase 30 H NMR(500MHz, CDCb): δ 1.10(3H,s), 1.26(3H,s), 2.20(3H,s), 2.25(3H,s), 2.86(4H,t), 3.26(4H,t), 3.77(3H,s), 4.25(lH,m), 6.17(3H,m), 6.68(lH,s), 6.82dH,s) Example 197 35 l-[(4,5-Dimethyl-2-methoxyphenyl)aminothiocarbonyl]-4-(3,δ-dimethoxy phenyDpiperazine: (a) Phenyl N-(4,5-dimethyl-2-methoxyphenyDthiocarbamate: To 3,4-dimethyl-2-memoxyaniline(4.50g, 0.03mol), methylene chloride( 100ml) was added and then phenyl chlorothionoformate(5.16g, 0.03mol) was added slowly. The resulting mixture was stirred for 2 δ hours, and thereto water(150ml) was added. The resulting mixture was extracted with methylene chloride and purified by column chromatography to obtain the titled compound. yield: 92% J H NMR(500MHz, CDCb): δ 2.21 (3H,s), 2.25(3H,s), 3.85(3H,s), 0 6.80(lH,s), 6.93(5H,m), 7.31 (lH,s) (b) l-[(4,5-Dimethyl-2-methoxyphenyl)aminothiocarbonyl]-4- (3,δ-dimethoxyphenyl)piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)thiocarbamate(0.2g, 0.7mmol) and l-(3,5-dimethoxyphenyl)piperazine(0.16g, 0.7mmol) were dissolved in 5 tetrahydrofurandOml) and thereto DBU(0.11g, 0.7mmole) was added, followed by stirring at room temperature for 2 hours. The resulting product was concentrated and purified by chromatography to obtain the titled compound, yield: 84% 0 m.p.: 128-129 * C Η NMR(500MHz, CDCb): S 2.20(3H,s), 2.24(3H.s), 2.32(6H,s), 3.37(4H,t), 3.83(3H,s), 4.08(4H,t), 6.69(3H t m), 7.39(lH.m). 7.47(lH,s) Mass(EI) m/z : Calcd for C22H29N3O3S1 415.1929, found 415.1912 25 Example 198 1 -[(4,5-Dimethyl-2-methoxyphenyl)aminothiocarbonyl] -4- (3,5-dimethylphenyl)piperazine: Phenyl N-(4,5-dimethyl-2-methoxyphenyl)thiocarbamate and l-(3,5-dimethylphenyl)perazine were reacted by the same way with the 30 example 197 to obtain the titled compound. yield : 90% m.p.: 164-165 * 0 1H NMR(δ00MHz, CDCb): δ 2.20(3H,s), 2.24(3H,s), 2.32(6H,s), 3.37(4H,t), 3.83(3H,s), 4.08(4H,t), 6.69(3H,m), 7.39dH,m), 7.47dH,s) 35 Mass(EI) m/z : Calcd for C22H29N3O1S1 383.2031, found 383.2086 Example 199 1 -[(4,5-Dimethyl-2-methoxyphenyl)aminothiocarbonyl] -4- (2,3-dimethylphenyl)piperazine: Phenyl N-(4,5-dimethyl-2-methoxyphenyl)thiocarbamate and l-(2,3-dimethylphenyl)piperazine were reacted by the same way with the example 197 to obtain the titled compound. yield: 89% m.p.: 151-152 * 0 1H NMR(500MHz, CDCb): δ 2.21(3H,s), 2.24(3H,s), 2.29(6H,s), 3.03(4H,t), 3.83(3H,s), 4.10(4H,t), 6.69dH,s), 6.97(2H,m), 7.11(lH,t) Example 200 l-[(4,5-Dimethyl-2-methoxyphenyl)aminothiocarbonyl]-4- (3.δ-difluorophenyl)piperazine: Phenyl N-(4,5-dimethyl-2-methoxyphenyl)thiocarbamate and l-(3,δ-difluorophenyl)piperazine were reacted by the same way with the example 197 to obtain the titled compound. yield : 92% m.p.: 167-168 * 0 J H NMR(δ00MHz, CDCb): δ 2.20(3H,s), 2.24(3H,s), 2.27(3H,s), 2.32(3H,s), 3.39(4H,tJ=δ.0Hz), 3.83(3H,s). 4.14(4H,t), 6.70(lH,s), 6.80(2H,m), 7.36(lH,s), 7.44(lH,s) Example 201 1 -[(4,5-Dimethyl-2-methoxyphenyl)aminothiocarbonyl]-4- (3,δ-dichlorophenyl)piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)thiocarbamate and l-(3,δ-dichlorophenyl)piperazine were reacted by the same way with the example 197 to obtain the titled compound. yield: 8δ% m.p.: 188-189 * 0 , Η NMR(500MHz, CDCb): δ 2.20(3H,s), 2.24(3H,s), 3.3δ(4H,tJ=δ.0Hz), 3.83(3H,s), 4.04(4H,tJ=5.0Hz), 6.70(2H,m), 6.83(lH,s), 7.30(lH,s), 7.48(lH,s) Mass(EI) m z : Calcd for C20H24N3O2CI1 423.0938, 423.0956 Example 202 l-[(4,δ-Dimethyl-2-methoxyphenyl ) aminothiocarbonyl]-4-(2-fluorophenyl) piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)thiocarbamate and δ l-(2-fluorophenyl)piperazine were reacted by the same way with the example 197 to obtain the titled compound. yield: 87% m.p.: 139-140 * 0 Η NMR(δ00MHz, CDCb): δ 2.21 (3H,s), 2.24(3H,s), 3.40(4H,t), 0 3.83(3H,s), 4.25(4H,t), 6.70(lH,s), 7.13(3H,m), 7.37(2H,m) Example 203 l-[(4,5-Dimethyl-2-methoxyphenyl)aminothiocarbonyl]-4-(2-chlorophenyl )piperazine: lδ Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)thiocarbamate and l-(2-chlorophenyl)piperazine were reacted by the same way with the example 197 to obtain the titled compound. yield: 85% m.p.: 115-116 * 0 20 * H NMR(500MHz, CDCb): δ 2.21 (3H,s), 2.24(3H,s), 3.18(4H,t), 3.83(3H,s), 4.09(4H,t), 6.69(lH,s), 7.0δ(2H,m), 7.33(lH,s), 7.41(2H.m) Example 204 l-[(4,5-Dimethyl-2-methoxyphenyl)aminothiocarbonyl]-4- 2δ (2-methoxyphenyl)piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)thiocarbamate and l-(2-methoxyphenyl)piperazine were reacted by the same way with the example 197 to obtain the titled compound. yield: 90% 30 m.p.: oil phase l H NMR(δOOMHz, CDCb): δ 2.20(3H,s), 2.23(3H,s), 3.14(4H,t,J=5.0Hz), 3.82(3H,s), 3.88(3H,s), 4.06(4H,t,J=δ.0Hz), 6.69(lH,s), 6.94(3H,m), 7.30(lH,s), 7.40(lH,s) 35 Example 205 l-[(4,5-Dimethyl-2-methoxyphenyl)aminothiocarbonyl]-4- (2-methylthiophenyl)piperazine: Phenyl N-(4,5-dimethyl-2-methoxyphenyl)thiocarbamate and l-(2-methylthiophenyl)piperazine were reacted by the same way with the example 197 to obtain the titled compound. δ yield: 93% iap.: 136-137 * C V I-I NMR(500MHz, CDCb): δ 2.20(3H,s) t 2.26(3H,s), 2.45(3H,s), 3.33(4H,t), 3.82(3H,s), 4.39(4H,t), 6.74(lH,s), 7.16(3H,m), 7.47(2H,m) 10 Example 206 l-[(4,5-Dimethyl-2-methoxyphenyl)aminothiocarbonyl]-4- (3-hydroxyphenyl)piperazine: Phenyl N-(4,5-dimethyl-2-methoxyphenyl)thiocarbamate and l-(3-hydroxyphenyl)piperazine were reacted by the same way with the lδ example 197 to obtain the titled compound. yield: 77% m.p.: Decomposed(200 * C ) Η NMR(δOOMHz, CDCb): δ 2.17(3H,s), 2.23(3H,s), 3.31(4H,t), 3.82(3H,s), 4.03(3H,t), 6.37(2H,m), 6.47(lH,d), 6.69dH,s), 7.13dH,t), 20 7.4δdH,s) Example 207 l-[(4,δ-Dimethyl-2-methoxyphenyl)aminothiocarbonyl]-4- (2-phenoxyphenyl)piperazine: 25 Phenyl N-(4,5-dimethyl-2-methoxyphenyl)thiocarbamate and l-(2-phenoxyphenyl)piperazine were reacted by the same way with the example 197 to obtain the titled compound. yield: 86% m.p.: oil phase 30 Η NMR(500MHz, CDCb): δ 2.17(3H,s), 2.24(3H,s), 3.19(4H,t), 3.80(3H,s), 3.85(4H,t), 6.66(lH,s), 6.91(2H,m), 6.98(lH,m), 7.05(3H,m), 7.13(lH,m), 7.23(lH,m), 7.31(2H,m), 7.36(lH,s) Example 208 35 l-[(4,5-Dimethyl-2-methoxyphenyl)aminothiocarbonyl]-4- ( 2- i sopropeny lpheny 1 )piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)thiocarbamate and l-(2-isopropenylphenyl)piperazine were reacted by the same way with the example 197 to obtain the titled compound, yield: 75% 5 m.p.: 157-158 * 0 1H NMR(δ00MHz, CDCb): δ 2.20(3H,s), 2.21(3H,s), 2.24(3H.s), 3.19(4H,t), 3.82(3H,s ) , 4.05(4H,t), 5.07dH,s), 5.16dH,s), 6.69(lH,s), 7.11(3H,m), 7.33(lH,s), 7.45(lH,s) 0 Example 209 1 - [ (4,5-Dimethyl-2-methoxyphenyl)aminothiocarbony 1] -4 - (2-methoxy-5-methylphenyl)piperazine: Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)thiocarbamate and l-(2-methoxy-δ-methylphenyl)piperazine were reacted by the same way lδ with the example 197 to obtain the titled compound. yield: 87% m.p.: oil phase 1H NMR(δ00MHz, CDCb): δ 2.20(3H,s), 2.23(3H,s), 2.29(3H.s). 3.13(4H,t), 3.83(3H,s), 3.8δ(3H,s), 4.0δ(4H,t), 6.69(lH,s), 6.83(2H,m), 20 7.30(lH,s), 7.40(lH,s) Example 210 1 -[(4,δ-Dimethy l-2-methoxyphenyl)aminothiocarbony 1] -4 - ( 1 -naphthyl ) piperazine: 2δ Phenyl N-(4,δ-dimethyl-2-methoxyphenyl)thiocarbamate and l-(l-naphthyl)piperazine were reacted by the same way with the example 197 to obtain the titled compound. yield: 87% m.p.: 139-140 * 0 30 H NMR(500MHz, CDCb): δ 2.23(3H,s), 2.24(3H,s), 3.21(4H.t). 3.84(3H,s), 4.09(4H,t), 6.70(lH,s), 7.10(lH,d), 7.48(δH,m), 7.8δdH,m), 8.22(lH,d) Example 211 35 l-[(5-Acetyl-2-methoxy-4-methylphenyl)aminocarbonyl]-4- (3,δ-dimethoxyρhenyl)piperazine: Phenyl N-(5-acetyl-2-methoxy-4-methylphenyl)carbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound, yield: 91% δ m.p.: 103-105 * 0 * H NMR(δOOMHz, CDCb): δ 2.54(3H,s), 2.59(3H,s ) , 3.27(4H,t), 3.70(4H,t), 3.79(6H,s), 3.94(3H,s), 6.13(3Hjn), 6.70(lH,s), 7.05 ( lH,s ) , 8.72(lH,s ) Example 212 0 l-[(5-Acetyl-2-methoxy-4-methylphenyl)aminocarbonyl]-4-(3,δ-dimethy -lphenyDpiperazine: Phenyl N-(δ-acetyl-2-methoxy-4-methylphenyl)carbamate and l-(3,δ-dimethy lphenyDpiperazine were reacted by the same way with the example 170 to obtain the titled compound. lδ yield : 88% m.p.: 140-142 * 0 H NMR(δOOMHz, CDCb): δ 2.30(3H,s), 2.54(3H,s), 2.δ9(3H,s), 3.26(4H,t), 3.70(4H,t), 3.97(3H,s), 6.61(3H,m), 6.70 ( lH,s), 7.06dH.s), 8.72(lH,s) 20 Example 213 l-[(5-AcetyI-2-methoxy-4-methylphenyl)aminocarbonyl]-4-(3,δ-dichloro- phenyDpiperazine: Phenyl N-(δ-acetyl-2-methoxy-4-methylphenyl)carbamate and 25 l-(3,5-dichlorophenyl)piperazine were reacted by the same way with the example 170 to obtain the titled compound. yield: 78% m.p.: 170-172 * 0 1H NMR(δ00MHz, CDCb): δ 2.54(3H,s), 2.δ9(3H,s), 3.32(4H.t), 3.74(4H,t), 30 3.94(3H,s), 6.69dH,s), 6.86(3H,m), 7.04(lH,s), 8.69(lH,s) Example 214 1 - { [5- (1 -Hydroxy ethy l)-2-methoxy-4-methy lpheny Oaminocarbonyl ) -4 - (3,δ-dimethoxyphenyl)piperazine: 3δ 1 ~[(5- Acetyl-2-methoxy-4-methylphenyl)aminocarbonyl]-4- (3,δ-dimethoxyphenyl)piperazine(0.2g, 0.47mmol) was dissolved in anhydrous ethanoKlδml), and sodium borohydride(17mg) was added thereto, and then the resulting mixture was stirred at room temperature for 2 hours, concentrated under the reduced pressure to remove ethanol, and purified by column chromatography (ethylacetate:hexane = 1:2) to 5 obtain the titled compound, yield: 96% m.p.: 152-154 * 0 1H NMR(500MHz, CDCb): δ 1.41(3H,d), 2.32(3H,s), 3.27(4H,t), 3.71(4H,t), 3.79(6H,s), 3.87(3H,s), δ.04(lH,q), 6.10(3H,m), 6.63dH,s), 0 7.01 (lH,s), 8.22(lH,s) Example 21δ l-([δ-(l-Hydroxyethyl)-2-methoxy-4- ethylphenyl]aminocarbonyl}-4- (3,δ-dimethylphenyl)piperazine: lδ 1 -[(5- Acetyl-2-methoxy-4-methylphenyl)aminocarbonyl]-4- (3,5-dimethylphenyl)piperazine was reacted by the same way with the example 214 to obtain the titled compound. yield: 96% m.p.-' 140-142 * 0 20 J H NMR(500MHz, CDCb): δ 1.48(3H,d), 2.33(3H,s), 3.26(4H,t), 3.68(4H,t), 3.87(3H,s), δ.06(lH,q), 6.61(3H,m). 6.64(lH,s), 7.01(lH,s), 8.22(lH,s) Example 216 25 1 -[(2-Methoxy-4-methyl-5-vinylphenyl)aminocarbonyl]-4- (3,δ- dimethoxyphenyDpiperazine: l-{[δ-(l-Hydroxyethyl)-2-methoxy-4-methylphenyl]aminocarbonyl}-4- (3,δ-dimethoxyphenyl)piperazine(0.2g, 0.47mmol) was dissolved in chloroform(15ml), pyridium p-toluenesulfonate(0.12g, 0.47mmol) was 30 added thereto, and the resulting mixture was refluxed for 16 hours, and concentrated under the reduced pressure to remove chloroform and purified by column chromatography(ethylacetate:hexane=l:2) to obtain the titled compound. yield: 84% 35 m.p.: 163-165 * 0 1H NMR(500MHz, CDCb): δ 2.31(3H,s), 3.23(4H,t), 3.δ8(4H.t). 3.77(6H,s), 3.87(3H,s), 5.20(lH,d), 5.62(lH,d), 6.59(3H,m), 6.63(lH,s), 6.88(lH,t), 6.99dH,s), 8.32dH,s) Example 217 δ l-[(2-Methoxy-4-methyl-δ-vinylphenyl)aminocarbonyl]-4- (3,5-dimethylphenyDpiperazine: l-{[δ-(l-Hydroxyethyl)-2-methoxy-4-methylphenyl]aminocarbonyl}-4- (3,δ-dimethylphenyl)piperazine was reacted by the same way with the example 216 to obtain the titled compound. 10 yield: 82% m.p.: 201-203 * 0 Η NMR(500MHz, CDCb): δ 2.29(6H,s), 2.34(3H,s), 3.24(4H,t), 3.68(4H,t), 3.87(3H,s), δ.22(lH,d), δ.66(lH,d), 6.δ9(3H,m), 6.63(lH,s), 6.86(lH,t). 7.02(lH,s), 8.32(lH,s) lδ Example 218 l-[(δ-Acetyl-2-methoxy-4-methylphenyl)aminothiocarbonyl]-4- (3,δ-dimethoxyphenyl)piperazine: Phenyl N-(δ-acetyl-2-methoxy-4-methylphenyl)thiocarbamate and 20 l-(3,δ-dimethoxyphenyl)piperazine were reacted by the same way with the example 197 to obtain the titled compound. yield: 82% m.p.: 163-16δ * C * H NMR(500MHz, CDCb): δ 2.16(3H,s), 2.δ6(3H,s), 3.3δ(4H,t), 25 3.91(6H,s), 4.03(3H,s), 4.13(4H,t), 6.06(3H,m), 6.73(lH,s), 8.62(lH,s) Example 219 l-[(5-Acetyl-2-methoxy-4-methylphenyl)aminothiocarbonyl]-4- (3,δ-dimethylphenyl)piperazine: 30 Phenyl N-(δ-acetyl-2-methoxy-4-methylphenyl)thiocarbamate and l-(3,δ-dimethy lphenyDpiperazine were reacted by the same way with the example 197 to obtain the titled compound. yield: 79% m.p.: 180-182 * 0 35 1H NMR(500MHz, CDCb): δ 2.29(6H,s), 2.δ7(6H,s), 3.32(4H,t). 3.92(3H,s), 4.12(4H,t), 6.56(3H,m), 6.72dH,s), 7.39(lH,s), 8.63(lH,s) Example 220 l-[(δ-Acetyl-2-methoxy-4-methylphenyDaminothiocarbonyl]-4- (3,δ-dichlorophenyDpiperazine: δ Phenyl N-(δ-acetyl-2-methoxy-4-methylphenyl)thiocarbamate and l-(3,δ-dichlorophenyl)piperazine were reacted by the same way with the example 197 to obtain the titled compound. yield: 79% m.p.: 201-203 * 0 0 * H NMR(δ00MHz, CDCb): δ 2.20(3H,s), 2.δ7(3H,s), 3.46(4H,t), 3.92(3H,s), 4.2δ(4H,t), 6.64(lH,s), 6.88(3H,m), 7.72dH,s), 8.δ7(lH,s) Example 221 l-{[δ-(l-Hydroxyethyl)-2-methoxy-4-methylphenyl]aminothiocarbonyl}-4 5 -(3,5-dimethoxyphenyDpiperazine: l-[(5-Acetyl-2-methoxy-4-methylphenyl)aminothiocarbony]-4- (3,δ-dimethoxyphenyl)piperazine was reacted by the same way with the example 214 to obtain the titled compound. yield: 94% 0 m.p.: 146-148 * 0 1H NMR(500MHz, CDCb)-' δ 1.44(3H,d), 2.32(3H,s), 3.3δ(4H,t), 3.78(6H,s), 3.84(3H,s), 4.11(4H,t), δ.06(lH,q), 6.13(3H,m), 6.66(lH.s), 7.41(lH,s), 7.77dH,s) 5 Example 222 1 -{[δ- (1 -Hydroxyethyl)-2-methoxy-4-methylphenyl]aminothiocarbonyl }-4 -(3,δ-dimethylphenyl)piperazine: l-[(δ-Acetyl-2-methoxy-4-methylphenyl)aminothiocarbony]-4- (3,δ-dimethylphenyl)piperazine was reacted by the same way with the 30 example 214 to obtain the titled compound. yield: 93% m.p.: 150-152 * 0 1H NMR(500MHz, CDCb): δ 1.44(3H,d), 2.29(6H,s), 2.32(3H,s), 3.30(4H,t), 3.84(3H,s), 4.07(4H,t), δ.06(lH,q), 6.61(3H,m), 6.66(lH,s), 35 7.38dH,s), 7.79(lH,s) Example 223 l-{[δ-(l-Hydroxyethyl)-2-methoxy-4-methylphenyl]aminothiocarbonyl)-4 -(3,δ-dichlorophenyl)piperazine: l-[(δ-Acetyl-2-methoxy-4-methylphenyl)aminothiocarbony]-4- δ (3,δ-dichlorophenyl)piperazine was reacted by the same way with the example 214 to obtain the tided compound. yield: 77% m.p.: 166-168 * 0 1H NMR(500MHz, CDCb): δ 1.45(3H,d), 2.33(3H,s), 3.35(4H,t), 10 3.84(3H,s), 4.03(4H,t), δ.07dH,q), 6.68(3H,m), 6.83dH,s), 7.37(lH,s), 7.82(lH,s) Example 224 Ethyl 2-({[4-(3,δ-dimethoxyphenyl)piperazino]carbonyl}-2-methoxy-4,δ- lδ dimethylanilino) acetate : l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3,δ-dimethoxy phenyl)piperazine(0.2g, O.δmmol) was dissolved in dimethylformamidedδml), sodium hydride(18.δmg, O.δmmol) was added thereto, and the resulting mixture was stirred at room temperature. 20 Then, ethyl bromoacetate(83.δmg, O.δmmol) was added thereto and the resulting mixture was stirred for 3 hours, concentrated under the reduced pressure to remove the used solvent and purified by column chromatography(ethylacetate:hexane=l:2) to obtain the titled compound. yield: 79% 2δ m.p.: oil phase 1H NMR(500MHz, CDCb): δ 1.36(3H,t), 2.15(3H,s), 2.23(3H,s), 2.91 (4H,t). 3.22(4H,t), 3.82(6H,s), 4.12(3H,s), 4.18(2H,s), δ.98(3H,m), 6.69(lH,s). 7.03(lH,s) 30 Example 22δ Ethyl 2-({[4-(3,δ-dimethylphenyl)piperazino]carbonyl}-2-methoxy-4,δ- dimethylanilino)acetate : l-[(4,δ-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4- (3,δ-dimethylphenyl)piperazine was reacted by the same way with the 35 example 224 to obtain the titled compound. yield: 78% m.p.: oil phase 1H NMR(500MHz, CDCb): δ 1.26(3H,t), 1.56(6H,s), 2.17(3H,s), 2.24(3H,s), 3.32(4H,t), 3.52(4H f t), 3.82(3H,s), 4.15(2H,q ) , 4.18(2H,s), 6.70(3H,m), 6.94(lH,s), 7.46UH,s) 5 Example 226 2- ( { [4- (3,δ-Dimethoxypheny l)piperazino]carbony 1 } -2-methoxy-4,δ- dimethylanilino)acetic acid: Ethyl 2-({[4-(3,δ-dimethoxyphenyl)piperazino]carbonyl}-2-methoxy-4,5- 0 dimethylanilino)acetate(200mg, 0.41mmole) was dissolved in dioxane÷distilled water(4 , 15ml), lithium hydroxide monohydrate(50.7mg, 1.23mmol) was added thereto, and then the resulting mixture was stirred at room temperature for 3 hours, acidified with lN-hydrochloric acid, extracted with ethylacetate, filtered to dryness, concentrated under lδ the reduced pressure to remove the used solvent, and purified by column chromatography (ethylacetate:hexane= 1:2) to obtain the titled compound. yield: 80% m.p.: 188-189 * 0 20 3 H NMR(δ00MHz, CDCb): δ 2.14(3H,s), 2.23(3H,s), 2.93(4H,t), 3.35(4H,t). 3.75(6H,s), 3.87(3H,s), 4.18(2H,s), δ.96(3H,m), 6.71(lH,s), 7.71(lH.s) Example 227 2- ( { [4- (3,5-Dimethylphenyl)piperazino]carbonyl } - 2-methoxy -4,δ- 2δ dimethylanilino)acetic acid: Ethyl 2-({[4-(3,δ-dimethylphenyl)piperazino]carbonyl)-2-methoxy-4,δ- dimethylanilino)acetate was reacted by the same way with the example 226 to obtain the titled compound. yield: 78% 30 m.p.: 170-171'C 1H NMR(500MHz > CDCb): δ 2.13(3H,s), 2.24(9H,s), 2.91 (4H,t), 3.3δ(4H,t), 3.83(3H,s), 4.18(2H,s), 6.4δ(3H,m), 6.70(2H,s), 6.80(lH,s) Example 228 35 l-[(2-Hydroxy-4,δ-dimethylphenyl)aminocarbonyl]-4- (3,δ-dimethoxyphenyl)piperazine: (a) 4,δ-Dimethyl-2-nitrophenol: To 3,4-dimethylphenol(12.1g, O.lmol), trifluoroacetic acid(2δ0ml) was added, and in water bath sodium nitrite(12.4g, 0.18mol) was added δ slowly. The resulting mixture was stirred at room temperature for 14 hours and concentrated under the reduced pressure to remove trifluoroacetic acid, followed by addition of waterdδOml), extracted with ether and purified by column chromatography to obtain the titled compound. 0 yield: 80% Η NMR(500MHz, CDCb): δ 2.23(3H,s), 2.29(3H,s), 6.93(lH,s), 7.84(lH,s) (b) 4,δ-Dimethyl-2-hydroxyaniline: lδ To 4,δ-dimethyl-2-nitrophenol(11.7g, 0.07mol), tetrahydrofuran (100ml) and ethanol(40ml) were added, and 10% palladium/activated carbon(0.57g) was added slowly, and then the mixture was hydrogenated for 5 hours. The reaction mixture was concentrated and chromatographed by the same way above to obtain the titled compound. 20 yield : 77% l H NMR(δ00MHz, CDCb): δ 2.11 (6H,s), 6.δ6(2H,s) (c) Phenyl N-(4,δ-dimethyl-2-hydroxyphenyl)carbamate: To 4,δ-dimethyl-2-hydroxyaniline(6.80g, O.Oδmole), methylene 2δ chloridedOOml) was added and then phenyl chloroformate(8.0g, O.Oδmole) was added slowly. After stirring for 2 hours, addition of waterdδOml), extraction with methylene chloride and column chromatography gave the titled compound. yield: 92% 30 Η NMR(500MHz, CDCb): δ 2.17(6H,s), 6.74(lH.s), 7.15(δH.m). 7.31 (lH,s) (d) Phenyl N-[2- (t-butyldimethylsilyloxy )-4,δ-dimethylphenyl]carbamate: To a mixture of phenyl N-(4,δ-dimethyl-2-hydroxyphenyl)carbamate 35 (7.72g, 0.03mol) and imidazole(2.2g, 33mmol), methylene chloridedOOml) was added, and with stirring t-butyldimethylsily .chloride (5.0g, 33mmole) was added. Then the mixture was stirred for 2 hours, and water(150ml) was added thereto. The resulting mixture was extracted with methylene chloride, dried, concentrated under the reduced pressure and purified by column chromatography to obtain the titled compound. 5 yield: 83% 1H NMR(500MHz, CDCb): δ 0.27(6H,s), 0.98(9H,s), 2.17(6H,s), 7.12(5H,m), 7.30(2H,s) (e ) 1 -[(2-Hydroxy-4,5-dimethylphenyl)aminocarbonyl]-4- o (3,δ-dimethoxyphenyl)piperazine: Phenyl N-[2-(t-butyldimethylsilyloxy)-4,δ-dimethylphenyl]carbamate (0.17g, O.δmmole) and l-(3,δ-dimethoxyphenyl)piperazine(0.13g, 0.6mmole) were dissolved in tetrahydrofuran(lθml), and thereto with stirring DBU(0.09g, O.βmmole) was added, and the resulting mixture lδ was stirred for 2 hours, concentrated and chromatographed to obtain the titled compound, yield: 87% m.p.: 14δ-146 * C 1H NMR(500MHz, CDCb): δ 2.14(3H,s), 2.18(3H,s), 3.26(4H,t), 3.67(4H,t). 20 3.79(6H,s), 6.07(3H,m), 6.40(3H,m), 6.67(lH,s), 6.82(lH,s), 8.87(lH,s) Example 229 l-[(2-Hydroxy-4,δ-dimethylphenyl)aminocarbonyl]-4- (3,δ-dimethoxyphenyl)piperazine: 2δ Phenyl N-[2-hydroxy-4,δ-dimethylphenyl)carbamate and l-(3,δ-dimethylphenyl)piperazine were reacted by the same way with the example 228 to obtain the titled compound. yield: 84% m.p.: 160-162 * 0 30 ! H NMR(500MHz, CDCb): δ 2.13(3H,s), 2.17(3H,s), 2.31 (6H,s), 3.26(4H,t), 3.7δ(4H,t), 6.73(3H,m), 6.81(lH,s), 8.86(lH,s) Example 230 l-[(2-Hyclroxy-4,δ-dimethylphenyl)aminocarbonyl]-4-(3,δ-difluorophenyl) 35 piperazine: Phenyl N-[2-hydroxy-4,δ-dimethylphenyl)carbamate and l-(3,δ-difluorophenyl)piperazine were reacted by the same way with the example 228 to obtain the titled compound, yield: 80% m.p.: lδ2-154 * C Η NMR(500MHz, CDCb): δ 2.17(3H,s), 2.20(3H,s), 3.30(4H,t), 3.70(4H,t), 6.40(3H,m), 6.70(lH,s), 6.82dH,s), 6.98dH,s) Example 231 1 - [ (2-hy droxy-4,5-dimethylpheny Daminocarbonyl] -4 - (3,δ-dichloropheny 1) piperazine: Phenyl N-(2-hydroxy-4,δ-dimethylphenyl)carbamate and l-(3,δ-dichlorophenyl)piperazine were reacted by the same way with the example 228 to obtain the titled compound. yield: 77% m.p.: oil phase Η NMR(500MHz, CDCb): δ 2.1δ(3H,s), 2.20(3H,s), 3.32(4H,t), 3.69(4H,t), 6.29(3H,m), 6.69(lH,s), 6.81 (lH.s), 8.65dH,s) δ Antitumor activities of compounds of the present invention were tested in vitro against δ kinds of human tumor cell lines and 2 kinds of leukemia tumor cell lines. The method and result of in vitro tests is as follows. SKMEL-2 (human melanoma) B. SRB Assay Method. a. Human solid tumor cell lines, Aδ49(non-small lung cell), SKMEL-2(melanoma), HCT-lδ(colon), SKOV-3(ovarian), XF-498(CNS) were cultured at 37 * 0 , in δ% C0 2 incubators using the RPMI 1640 media containing 10% FBS, while they were transfer- cultured successively once or twice per week. Cell cultures were dissolved in a solution of 0.25% trypsin and 3 mM CDTA PBS(-) and then cells were separated from media which the cells were sticked on. b. δ x l0 3 2 10 4 cells were added into each well of 96-well plate and cultured in δ% CO2 incubator, at 37 * 0, for 24 hours. c. Each sample drug was dissolved in a little DMSO and diluted with the used medium to a prescribed concentration for experiments, wherein the final concentration of DMSO was controlled below 0.δ%. d. Medium of each well cultured for 24 hours as above b. was removed by aspiration. Each 200 μ \ of drug samples prepared in c. was added into each well and the wells were cultured for 48 hours. Tz(time zero) plates were collected at the point of time drugs were added. e. According to the SRB assay method, cell fixing with TCA, staining with 0.4% SRB solution, washing with 1% acetic acid and elution of dye with lOmM Tris solution were carried out on Tz plates and culture-ended plates, and then, OD values were measured at δ20 n . δ C. Calculation of result a. Time zero(Tz) value was determined with measuring the SRB protein value at the point of time drugs were added. 10 b. Control value(C) was determined with the OD value of an well untreated with drug. c. Drug-treated test value(T) was determined with the OD value of lδ drug-treated well. d. Effects of drugs were estimated with growth stimulation, net growth inhibition, net killing etc. calculated from Tz, C and T. 20 e. If T ≥ Tz, cellular response function was calculated by 100x(T-Tz)/(C-Tz), and if T < Tz, by 100 x (T-Tz)/Tz. The results are shown in the next table 1. * REFERENCE 2δ D P. Skehan, R. Strong, D Scudiero, A. Monks, J. B. Mcmahan, D. T. Vistica, J. Warren, H. Bokesh, S. Kenny and M. R. Boyd : Proc. Am. Assoc. Cancer Res., 30, 612(1989) 2) L. V. Rubinstein, R. H. Shoemaker, K. D. Paull, R. M. simon, S. Tosini, P. Skehan, D. Scudiero, A. Monks and M. R. boyd. ; J. Natl. 30 Cancer Inst, 82, 1113(1990) 3) P. Skehan, R. Strong, D. Scudiero, A. monks, J. B. Mcmahan, D. T. Vistica, J. Warren, H. Bokesh, S. Kenny and M. R. Boyd. , Natl. Cancer Ins., 82, 1107(1990) 35 D. Results. It was found that compounds of the present invention have the superior antitumor activities than those of cisplatin, one control, and equal to or higher antitumor activities than those of adriamycin, another control, against human solid cancer cell lines. Table 1. Ε∑forμg/ml Experimental 2. In vitro antitumor effects against animal leukemia cells. A. Materials : Tumor cell lines : L1210(mouse leukemia cell) P388 (mouse lymphoid neoplasma cell) B. Method : Dye Exclusion Assay. 1) The concentrations of L1210 and P388 cells being cultured in RPMI 1640 media containing 10% FBS were regulated to 1 x 10° cells/ml. 2) Sample drugs of respective concentrations diluted in the ratio of log doses were added into cell media, and cultured at 37 * C, for 48 hours, in 50% CO2 incubator, and then viable cell number was measured by dye exclusion test using trypan blue. 3) The concentration of sample compounds showing 50 % cell growth inhibitiondCδo) compared with the control were determined and listed in the table 2 below. * REFERENCE 1) P. Skehan, R. Strong, D. Scudiero, A. Monks, J. B. Mcmahan, D. T. Vistica, J. Warren, H. Bokesh, S. Kenney and M. R. Boyd. : Proc. Am. Assoc. Cancer Res., 30, 612(1989). 2) L. V. Rubinstein, R. H. Shoemaker, K. D. Paull, R. M. Simon, S. Tosini, P. Skehan, D. Scudiero, A. Monks, J. Natl. Cancer Inst., 82, 1113(1990) 3) P. Skehan, R. Strong, D. Scudiero, J. B. Mcmahan, D. T. Vistica, J. Warren, H. Bokesch, S. Kenney and M. R. Boyd. : J. Natl. Cancer Inst., 82, 1107(1990) C. Results As the results of measurement of antitumor activities of compounds of the present invention against L1210 and P388 mouse cancer cells, it was found that the compounds tested have equal to or higher antitumor activities than those of the control drug, mitomycin C. Experimental 3. * In vivo antitumor effects against mouse leukemia P388 cells. A. Material of experiment BDF1 mice were used. B. Method of experiment 1) Leukemia P388 cells being transfer-cultured successively in δ DBA/2 mouse, were grafted into each mouse of a group comprising 8 mice of 6 week old BDF1 mouse with the dose of 1 x 10 6 cells/0.1ml. 2) Sample drugs were dissolved in PBS or suspended in 0.5% tween 80, and then injected into abdominal cavity of mouse at each 0 prescribed concentration on days 1, 5, 9, respectively. 3) With observation everyday, survival times of tested mice were measured. Antitumor activities was determined in such a manner that the increasing ratio(T/C%) of average survival days of drug-treated 5 groups compared with the control group was calculated using the mean survival times of each tested groups. The results are shown at the next table 3. 0 25 30 3δ * REFERENCE A. Goldin et al.: Euro. J. Cancer, 17, 129 (1981). C. Result Through in vivo experiments using P388 mouse cancer cells, significant antitumor effect of the compounds of examples were observed. Experimental 4. Acute toxicity test (LD∞) •' Litchfield-Wilcoxon method. 6 weeks old ICR mice(male 30±2.0g) were fed freely with solid feed and water at room temperature, 23± 1 * C and at humidity 60±δ%. Sample drugs were injected into the abdominal cavities of mice, while each group comprises 6 mice. Observed during 14 days, external appearances and life or dead were recorded, and then, visible pathogenies were observed from dead animals by dissection. LD50 value was calculated by Litchfiled-wilcoxon method. The results are shown at the next table 4. δ 0 δ 0 lδ 20 25 30 As described above, it was found that the compounds of the present invention are more safer and have superior antitumor activities to cisplatin, and accordingly have solved the problems of drugs by the 35 prior art such as restriction of dosage, toxicity, etc.

Claims: What is claimed: 1. A compound of the general formula(I) wherein Ri and R2 are independently hydrogen, substituted or unsubstituted Ci-Cβ alkyl, substituted or unsubstituted C3-G; cycloalkyl, substituted or unsubstituted C2-C8 unsaturated alkyl, ketone, substituted or unsubstituted aryl, substituted or unsubstituted C1-C4 alkoxy, substituted or unsubstituted arylhydroxy, substituted or unsubstituted amino, C1-C4 lower ester, C1-C4 lower thioester, thiol, substituted or unsubstituted carboxyl, epoxy, substituted or unsubstituted Cj-C lower thioalkoxy; or Ri and R2 are fused to form C3-C4 saturated or unsaturated chain! R3, R4, Rδ, Re and R7 are independently hydrogen, halogen, hydroxy, nitro, C1-C4 lower ester, C1-C1 lower alkyl, Cι-C 4 lower thioalkyl, substituted or unsubstituted C3-C6 cycloalkyl, Cj-C 4 lower alkoxy, C1-C4 lower thioalkoxy, substituted or unsubstituted aryl, substituted or unsubstituted lower arylalkoxy, substituted or unsubstituted lower alkylamino, or lower alkyl substituted or unsubstituted carbamate; or among R3, R4, Rs, Re and R7, two adjacent groups are bonded with each other to form 1,2-phenylene or 2,3-naphthylene; X is oxygen, sulfur, or substituted or unsubstituted i ino; Y is bonded at the 3-position or 4-position of the aromatic ring part wherein Y is oxygen or -NRβ- (wherein, Re is the same with the above-mentioned R3.); Z is hydroxy, C1-C4 lower alkoxy, C1-C4 lower thioalkoxy, substituted or unsubstituted aryloxy, C1-C4 lower alkylamino, substituted or unsubstituted cycloamino containing 1-5 nitrogen atoms; A is nitrogen or -CH=; and pharmaceutically acceptable acid addition salts thereof. 2. A process for the preparation of compound of the general formula(I) or a pharmaceutically acceptable acid addition salt thereof comprising reacting a compound of the general formula(a) with a -C(=X)- group-providing agent in the presence of organic solvent to obtain a compound of the general formula(b) and reacting the compound of the general formula(b) with a compound of the general formula(c). <c> (i) wherein, Ri, R2, R3, R4, Rs, Rδ, R7, A, X, Y and Z are as defined above and Lie is a leaving group . 3. A process for the preparation of compound of the general formual(Ib) by introducing Re providing agent into a compound of the general formula(la). wherein, Ri, R2, Ra, R4, R5, Re, R7, Re, A, X and Z are as defined above.

Inventors: CHO EUI-HWAN, CHUNG SUN-GAN, JOO JEONG-HO, KANG DONG-WOOK, KWON HO-SEOK, LEE JAE-EUNG, LEE SUN-HWAN, LEE YOUNG-HEE, CHO, EUI-HWAN, CHUNG, SUN-GAN, JOO, JEONG-HO, KANG, DONG-WOOK, KWON, HO-SEOK, LEE, JAE-EUNG, LEE, SUN-HWAN, LEE, YOUNG-HEE
Applicants: CHO EUI HWAN, CHUNG SUN GAN, JOO JEONG HO, KANG DONG WOOK, KWON HO SEOK, LEE JAE EUNG, LEE SUN HWAN, LEE YOUNG HEE, SAMJIN PHARM CO LTD, CHO, EUI-HWAN, CHUNG, SUN-GAN, JOO, JEONG-HO, KANG, DONG-WOOK, KWON, HO-SEOK, LEE, JAE-EUNG, LEE, SUN-HWAN, LEE, YOUNG-HEE, SAMJIN PHARMACEUTICAL CO., LTD.
Application year: 1997
Main classification: C07D213
IPC codes: A61K31, A61P35, C07D213, C07D215, C07D221, C07D295, C07D401, C07D409